Document:

EX-10.14

 Exhibit 10.14 

 

Certain confidential information contained in this document, marked by brackets, has been omitted because it is both (i)
not material and (ii) would be competitively harmful if publicly disclosed. 

 RAP License (08/2017) 

 
 

 
 Software License Agreement 

(Supersedes Two Prior Software License Agreements) 

LDiscovery, LLC 

THIS SOFTWARE LICENSE IS NOT A SALE. 

THIS AGREEMENT INCLUDES RESTRICTIONS 

AND TERMINATION PROVISIONS. 
 Relativity
ODA LLC 
 231 South LaSalle St. 
 8th Floor 
 Chicago, IL 60604 

(312) 263-1177 

www.relativity.com 

 SOFTWARE LICENSE AGREEMENT 

THIS SOFTWARE LICENSE AGREEMENT (“Agreement”) is made and entered into as of the 1st day of January, 2018 (“Effective Date”), by and between Relativity ODA LLC (“Relativity”), a Delaware limited liability company, with its principal place of
business for notices set forth in Section 12, and LDiscovery, LLC (“Client”), a Delaware limited liability company, with its principal place of business for notices set forth in Section 12. 

BACKGROUND 
 A. Relativity
and Client are parties to that certain Software License Agreement dated April 16, 2015, as amended from time to time (“Prior License Agreement”); 

B. Client recently acquired all or substantially all the assets of Kroll Ontrack, LLC (“Kroll”), including Kroll’s rights
and interests in that certain Software License Agreement between Relativity and Kroll dated October 1, 2013, as amended from time to time (the “Kroll Agreement”), which is scheduled to expire on November 30, 2018;
and 
 C. Relativity and Client mutually desire to: (i) enter into this Agreement on the terms contained herein; (ii) concurrently
supersede and terminate the Prior License Agreement; (iii) provide for the transfer of the Software under the Kroll Agreement to this Agreement; and (iv) terminate the Kroll Agreement. 

In consideration of the foregoing background statements and the mutual provisions herein, the parties agree as follows: 

1. Termination of Prior License Agreement; Transfer of Software under Kroll Agreement; Termination of Kroll Agreement; Software License;
Defined Terms. 
 a. On the Effective Date of this Agreement, except as provided to the contrary herein: (i) this
Agreement will supersede and replace the Prior License Agreement referred to above, and the Prior License Agreement shall be deemed to have expired; (ii) all payments and obligations under the Prior License Agreement accruing or arising prior
to the Effective Date hereof shall be made and performed in accordance with the Prior License Agreement; (iii) each obligation under the Prior License Agreement which expressly or by reasonable implication is intended to survive termination or
expiration shall so survive. Relativity will provide Client with a prorated credit against the amounts due under this Agreement for all prepaid amounts under the Prior License Agreement, as further set forth in Exhibit
A hereto. 
 b. On the Effective Date of this Agreement, the Kroll Agreement shall be deemed to have expired and
the Software licensed under the Kroll Agreement will be transferred to Client. Notwithstanding the foregoing: (i) the Analytics Volume Based Subscription granted to Kroll in the Twenty Ninth Amendment to the Kroll Agreement shall be terminated
as of the Effective Date hereof; (ii) the Legal Hold license granted to Client in New Exhibit A attached to the Ninth Amendment to the Kroll Agreement shall be terminated as of the Effective Date hereof; (iii) all payments and other
obligations under the Kroll Agreement accruing or arising prior to the Effective Date hereof shall be made and performed in accordance with the Kroll Agreement; (iv) all other obligations under the Kroll Agreement which expressly or by
reasonable implication are intended to survive termination or expiration shall so survive; and (v) any failure to make timely payment or performance of any such obligations under the Kroll Agreement shall be a violation of this Agreement.
Relativity will provide Client with a prorated credit against the amounts due under this Agreement for all prepaid amounts under the Kroll Agreement, as further set forth in Exhibit A hereto. 

  
 1 

 c. Relativity grants Client, and Client accepts, a
non-exclusive, non-transferable, non-sublicensable, license (“License”) to use the Software products identified on Exhibit A commencing on the Effective
Date of this Agreement and during the Term in Exhibit A or until any earlier termination as provided in this Agreement, all on and subject to all terms of this Agreement. Capitalized terms not otherwise defined in this Agreement shall have the
meanings set forth in Exhibit B. 
 2. Payments. In consideration of the License, Client shall pay Relativity the amounts under
Exhibit A and as described further in Exhibit B. All dollar amounts under this Agreement shall be paid in US dollars without adjustment for changes in exchange rates, except as may be expressly provided in Exhibit A. Relativity
may apply payments to any Client obligations that are already due or past due, and may reallocate payments previously applied to earlier invoices so those payments apply to current invoices for other amounts that are already due or past due without
regard to obligations or invoices Client designates. 
 3. Services and Updates. This Agreement includes, without additional charge,
customer support services as provided in Exhibit C, and Relativity may provide other services that Client requests from time to time (collectively, “Services”). This Agreement also includes, without additional charges,
Critical Patch Releases, Minor Updates, Minor Releases and Major Releases, but does not include Add-Ons, as further described in Exhibit C.  

4. Money Back Warranty of Performance and Services 

a. Performance and Services. Subject to the other provisions of this Agreement: (i) Relativity warrants to Client that the
Software will perform substantially in conformance with Relativity’s written functionality description (“Specifications”) contained in Relativity’s user Documentation for the Software for three years
(“Warranty Period”) following the Effective Date, and (ii) in addition, Relativity will provide the Services substantially in conformance with the provisions of this Agreement. 

b. Warranty and Continuing Support Services. If at any time during the Warranty Period, Client notifies Relativity and demonstrates
that the Software does not perform substantially in conformance with the Specifications in violation of this warranty, Relativity shall use commercially reasonable efforts to materially cure such
non-conformance, as promptly as commercially practicable and at Relativity’s expense (including parts and labor), whether by repairing or replacing the Software or any of its parts and components, subject
to the provisions below. Both during the Warranty Period and thereafter while this Agreement is in effect, Client may notify Relativity of service problems and Relativity will use commercially reasonable efforts to provide Services substantially in
accordance with the Exhibits. 
 c. Limitations. Client is not authorized to, and shall not, make any warranty, guarantee or
representation on behalf of Relativity or its vendors respecting the Software or Services to Client’s end users. The warranties and Services herein: (i) are limited to the Software alone; (ii) do not apply in case of any problems
arising from any combination or operation of the Software with other software, components, or equipment not provided by Relativity; and (iii) shall be void if non-conformance or problems result from
accident, abuse, misapplication, modifications to the Software not made or authorized in writing by Relativity, or any use other than the specific purpose for which the Software is designed. Relativity does not warrant that the Software, its
functions, or results of using the Software, will be suitable for Client’s intended use, or that the operation of the Software will be uninterrupted or Error-free, or that the Software will be secure from unauthorized access or hacking. The
express warranties made herein are in lieu of, and to the exclusion of, all other warranties, conditions or representations of any kind, express or implied, statutory or otherwise, relating to the Software

  
 2 

 
or Services. WITHOUT LIMITING THE GENERALITY OF THE FOREGOING, RELATIVITY EXPRESSLY DISCLAIMS ALL IMPLIED WARRANTIES, INCLUDING IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS OF THE SOFTWARE
FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT (INFRINGEMENT BEING COVERED BY THE EXPRESS PROVISIONS OF SECTION 9), AND ANY IMPLIED WARRANTIES OR OTHER OBLIGATIONS ARISING FROM COURSE OF PERFORMANCE, COURSE OF
DEALING OR USAGE OF TRADE, AND ALL SUCH WARRANTIES, CONDITIONS AND REPRESENTATIONS ARE EXCLUDED FROM THIS AGREEMENT AND WAIVED TO THE FULLEST EXTENT NOT PROHIBITED BY LAW. 

d. Termination and Refund. If Relativity fails to cure a breach of the warranty provided in this Section, or fails to provide the
Services as required under this Agreement, or determines that the cure or Services are impractical or unreasonable to provide in Relativity’s opinion (whether technically or economically), Client may terminate this Agreement in whole (or in
part with respect to any Software product or Service which is the subject of the failure and for which there are separate fees under this Agreement). In such case, Relativity will promptly refund any fees paid by Client for the Software (or Software
product or Service which is being terminated), in a prorated amount reflecting: (i) any portion of such fees reasonably allocable to any period of the Term when Client was not able to use, and did not use, the Software (or Software product or
Service which is the subject of the failure and for which there are separate fees under this Agreement) due to the breach of the warranty under this Section; and (ii) any portion of such fees that Client
pre-paid for any period of the Term following such early termination. This Section 4 contains the only liability and obligations of Relativity, and the only remedies of Client, for Relativity’s
breach of the warranties in this Section 4 and/or failure to provide Services in accordance with this Agreement. 
 5.
Confidentiality 
 a. Confidential Information. In connection with this Agreement, each party may receive materials or
learn information which is confidential and/or proprietary to the other party. Such materials or information shall be deemed “Confidential Information” for purposes of this Agreement if such materials or information are:
(i) marked or identified as “Confidential”; or (ii) of a nature, whether oral or written, that a reasonable business person or information technology worker would know or suspect it to be confidential or proprietary, or would
know or suspect that there may be a detrimental effect on the other party’s competitive position if generally known and/or known by other customers or a competitor. Confidential Information hereunder includes information relating to a
party’s business practices, products, product development, research, business operations (e.g. business direction, technology initiatives or marketing plans, customer information, source and object code, financial information and pricing rates
and methods), whether or not such information is identified as “Confidential” at the time of disclosure. In addition, Relativity’s Confidential Information includes the Software, all Documentation pertaining to the Software, and terms
of this Agreement. 
 b. Obligations. Each party receiving or learning Confidential Information of the other party shall maintain all
such Confidential Information in strict confidence. Each party shall: (i) not use any of the Confidential Information of the other party, except to the extent required for the performance of this Agreement; and (ii) not disclose
Confidential Information of the other party to any person or party during the Term of this Agreement and thereafter, except as expressly permitted herein. Each party further agrees to protect the Confidential Information of the other party with the
same degree of care as it uses to protect its own Confidential Information of like importance, but in no event less than reasonable care. The receiving party may only disclose Confidential Information to its employees, contractors, attorneys and
financial advisors (“Representatives”) having a “need-to-know” to carry out the obligations under this

  
 3 

 
Agreement. Each party will: (1) notify and inform its Representatives of such party’s obligations regarding Confidential Information; (2) obtain agreements from its Representatives
requiring them to comply with such obligations; and (3) be responsible for any breach of the confidentiality obligations in this Section by such party’s Representatives. In no event will the receiving party use Confidential Information of
the other party, directly or indirectly, in the conduct, or for the advancement, of the receiving party’s own business or in any way that is detrimental to the other party. Each party will notify the other party immediately after learning of,
or having reason to suspect, a breach of any confidentiality obligations in this Section. 
 c. Exceptions. Confidential Information
shall not include information and materials that are posted on the public areas of the parties’ web-sites or that the receiving party can demonstrate: (i) were generally available to or known by the
public at the time of disclosure or subsequent to disclosure (other than through unauthorized disclosure by the receiving party or its Representatives); or (ii) were received on a non-confidential basis
from a third party who, to the receiving party’s knowledge, is not under an obligation to maintain the confidentiality thereof, provided, this exemption shall not apply unless the receiving party obtains a written representation and
warranty from the third party stating that such information and materials are not subject to an obligation to maintain confidentiality; or (iii) were known by the receiving party on the Effective Date, provided, this exemption shall not
apply unless the receiving party has obtained such information and materials pursuant to sub-clauses (i) or (ii) or otherwise obtained written confirmation from the disclosing party that such information
and materials qualify for exemption from Confidential Information in connection with entering into this Agreement. The confidentiality obligations of this Section shall not prohibit disclosure of Confidential Information: (1) as required by
applicable disclosure Laws (but the receiving party shall, at the disclosing party’s expense, seek confidential treatment of such Confidential Information to the maximum extent permitted by Laws); or (2) in connection with a court order or
legal process requiring disclosure, in which case the party under order or process must, to the extent allowed by Laws, provide prompt notice of such order or process to the other party and reasonably cooperate, at the other party’s expense, in
any attempt to quash or limit such order or process. 
 6. Proprietary Rights. RELATIVITY AND ITS THIRD PARTY VENDORS OWN AND SHALL
CONTINUE TO OWN THE ENTIRE TITLE AND INTEREST IN AND TO ALL INTELLECTUAL PROPERTY AND OTHER PROPRIETARY RIGHTS RELATED TO THE SOFTWARE, AND ALL MODIFICATIONS, ENHANCEMENTS, UPDATES, AND DERIVATIVE WORKS, and any suggestions, ideas, enhancement
request, feedback, recommendations or other information provided by Client or any other party relating to the Software. Client shall not directly or indirectly infringe any Intellectual Property Rights or misappropriate any IP of Relativity or its
third party vendors. Nothing in this Agreement, or the negotiation or performance thereof, shall be construed as transferring to Client or any other party any IP or other proprietary rights of Relativity or its third party vendors. This Agreement is
not intended to, and does not, convey any license, by implication, estoppel or otherwise, under any patent, copyright or other Intellectual Property not expressly granted hereunder. All rights not expressly granted to Client under this Agreement are
reserved by Relativity. CLIENT SHALL RETAIN, PRESERVE, AND NOT COVER-UP OR OBSCURE, ANY TRADEMARK, TRADE NAME, COPYRIGHT NOTICE OR OTHER PROPRIETARY NOTICE ON ANY TRAINING MANUALS OR OTHER
DOCUMENTATION PROVIDED BY RELATIVITY AND ON ANY COPY OR PORTION OF THE SOFTWARE, INCLUDING, BUT NOT LIMITED TO, SOFTWARE MERGED INTO ANOTHER PROGRAM (PROVIDED, NO SUCH MERGER IS PERMITTED UNLESS EXPRESSLY ALLOWED UNDER THIS AGREEMENT). THE
LICENSE IS LIMITED TO THE INSTALLATION AND EXECUTION OF OBJECT CODE COPIES OF THE SOFTWARE. THIS LICENSE DOES NOT INCLUDE SOURCE CODE. 

  
 4 

 7. Restrictions On Software Use, Transfers, and Other Matters. Except as expressly
permitted in this Agreement, Client: (i) shall only provide access to the Software to end users on a hosted basis from Client’s own servers; and (ii) shall not, directly or indirectly (through any other party), during the Term or
thereafter, engage or permit any other person or party to engage in any of the following actions: 
 a. Sell, license, sublicense, rent,
lease, timeshare, assign, mortgage, pledge, encumber, or otherwise transfer the Software, the License, this Agreement, or any right or interest in any of the foregoing items, by operation of Law or otherwise, to any other person or party, except for
approved Transfers pursuant to Section 15.c. 
 b. Use or access the Software or make copies, except as expressly permitted in this
Agreement; frame, mirror or copy any of Relativity’s web-sites or any portions thereof or content thereon; publish or distribute any computer image or other content that suggests an inaccurate association
with Relativity or its products or an unauthorized endorsement by Relativity of any product or service. 
 c. Take any technological actions
to circumvent standard security practices for using the Software and/or to avoid paying the full amounts under this Agreement, including: (i) circumventing or automating the standard practice of having Designated Application Support
Administrators enable each Named User manually; (ii) circumventing the features contained in the Software for tracking and reporting data usage or the number of individual Named Users; or (iii) multiplexing or sharing individuals’
access to and/or use of the Software through middleware, transaction servers, multi-tiered architectures, or other methods. 
 d. Reverse
engineer, decompile, disassemble, modify, or translate the Software, or attempt to: (i) discover the source code of, or create Derivative Works from, the Software; (ii) build a competitive product or component using similar features,
functions or graphics, unless Client builds or enhances such product or component (1) without violating the foregoing restrictions and the other sub-clauses and sections of this Agreement (including
restrictions on accessing, copying and reverse engineering the Relativity software code), and (2) without infringing any Intellectual Property Rights or misappropriating any IP of Relativity or its third party vendors; or
(iii) substantially copy any particular features, functions or graphics. “Derivative Works” means every translation, portation, modification, correction, addition, extension, upgrade, improvement, compilation, abridgment or
other form in which an existing work may be recast, transformed or adapted. “Derivative Works” also includes any software, technology, methods or processes that a person skilled in the arts would consider to be derived from the Software or
from any Relativity technology, methods or processes protected by copyright, patent and/or trade secret laws. If Client or anyone else makes any modification to the Software, whether authorized or unauthorized, such modification shall be considered
Derivative Works and owned by Relativity. 
 e. Host the Software, administer the Software, or provide any services or functions respecting
or using any aspect of the Software, on behalf of any other party (“Other Vendor”) under any white label or private label re-hosting arrangement. Accordingly, Client shall at all times:
(i) prominently display Client’s name and logo on all landing pages and log-in screens for the Software; (ii) not use any Other Vendor’s name in any URL used, directly or indirectly, to
access the landing pages or log-in screens for the Software; and (iii) not permit any Other Vendor’s website to provide a link to any instances of the Software. Relativity has no obligation under
this Agreement to accept or respond to service calls or other communications from any Other Vendor or its customers. Client must not provide any of Relativity’s materials or other property to any Other Vendor, and Client must immediately
terminate Client’s arrangement with any Other Vendor at Relativity’s written request if, without express 

  
 5 

 
authorization in a written agreement between the Other Vendor and Relativity: (1) the Other Vendor’s web-site provides, directly or indirectly,
any link to any instances of the Software; or (2) the Other Vendor uses Relativity’s materials, or name or logo, the Software name or logo, or other names, logos or means of identifying Relativity or any products of Relativity or otherwise
violates Relativity’s IP rights. 
 8. Non-Solicitation. Each party agrees not to
solicit, directly or indirectly, any of the other party’s Workers to become a Worker for the soliciting party, without the other party’s written consent, during the Term and for the next twelve (12) months after the Term.
“Worker” herein means a person who is at the time of the solicitation, or was during the preceding twelve (12) months: (a) employed by, or engaged as an independent contractor in providing services to, the subject party at
least twenty (20) hours per week on average; or (b) employed by, or engaged as an independent contractor in providing services to, a third party and assigned to work on behalf of the subject party at least twenty (20) hours per week
on average. This Section shall: (i) prevent a party from indirectly soliciting the other party’s Workers by requesting that a recruiting firm or other third party contact such Workers; and (ii) not apply when a party’s Worker
initiates contact with the other party or a recruiting firm and/or responds to a job posting of the other party or a recruiting firm. 

9. IP Infringement Claims 

a. Indemnity. Subject to the other provisions of this Agreement, if any third party makes a claim against Client that
Client’s use of Relativity’s Software during the Term in accordance with this Agreement infringes on any U.S. Patent or other Intellectual Property Rights of such third party which are valid and legally enforceable in the United States
(“Claim”), Relativity shall, at Relativity’s sole expense: (i) defend or settle the Claim; and (ii) indemnify and hold Client harmless from and against any losses, damages, and expenses (including reasonable
attorneys’ fees) that are directly attributable to such Claim; provided that: (1) Client delivers written notice of the Claim to Relativity promptly and in no event later than fourteen (14) days after Client first knows of the
Claim (including knowledge based on any informal or preliminary allegations); (2) Relativity is given the sole authority to defend or settle the Claim; (3) Client does not compromise or settle the Claim or any aspect or portion thereof, or make
any admission or substantive response relating to the Claim, without Relativity’s prior written agreement; (4) Client takes commercially reasonable steps to mitigate any damage or loss; and (5) Client cooperates fully with all
reasonable requests of Relativity in connection with defending and settling any such Claim. 
 b. Limitations. Relativity’s
obligations under this Section do not apply to any Claim based on any: (i) use of the Software not in accordance with this Agreement; (ii) modification of the Software by any party other than Relativity; (iii) continued use of the
Software after the Term; (iv) prior Release of the Software, to the extent the Claim could have been avoided by using the most current Release; or (v) combination or operation of Relativity’s Software with other software, components,
data, or equipment not created by Relativity, to the extent the Claim could have been avoided in the absence of such combination or operation. 

c. Mitigation; Termination and Refund. Notwithstanding the foregoing, to mitigate exposure in connection with any Claim, or if
Relativity believes a Claim may be made, Relativity may, at Relativity’s option and sole expense: (i) obtain for Client a license to continue using Relativity’s Software in its existing form for the remainder of the Term free from the
Claim; (ii) modify Relativity’s Software for Client in an effort to avoid or minimize the Claim, without materially affecting the functionality of Relativity’s Software; (iii) obtain for Client a license to use other software
which is marketed to compete with Relativity’s Software (which may be a product made or marketed by the third party making the Claim); or (iv) terminate this Agreement and 

  
 6 

 
refund fees paid by Client for the Software in a prorated amount reflecting: (1) any portion of such fees applicable to any period of the Term when Client was not able to use, and did not
use, the Software due to the Claim; and (2) any portion of such fees that were pre-paid for any period of the Term following such early termination. This Section contains the only liability and
obligations of Relativity, and the only remedies of Client, for any Claims as described herein. THE EXPRESS PROVISIONS OF THIS SECTION ARE IN LIEU OF, AND TO THE EXCLUSION OF, ALL OTHER INDEMNITY AND CONTRIBUTION OBLIGATIONS OF ANY KIND, EXPRESS OR
IMPLIED, STATUTORY OR OTHERWISE, RELATING TO THE CLAIMS, AND ALL SUCH INDEMNITY AND CONTRIBUTION OBLIGATIONS ARE EXCLUDED FROM THIS AGREEMENT AND WAIVED TO THE FULLEST EXTENT NOT PROHIBITED BY LAW. 

10. Termination and Remedies. This Agreement shall automatically expire and terminate at the end of the Term. The parties further agree
as follows: 
 a. Violation of Confidentiality. If either party violates the provisions of this Agreement respecting the other
party’s Confidential Information, the other party may terminate this Agreement immediately upon notice to the violating party. 
 b.
Violation of IP or Certain Other Provisions. Relativity may terminate this Agreement immediately upon notice to Client if Client violates Section 6 respecting IP or other rights, the restrictions set forth in Section 7, or the
restrictions set forth in section 15.c. 
 c. Failure to Pay. Payments under this Agreement are due thirty (30) days after
billed. If a payment is not made within thirty (30) days after the payment is due (i.e., sixty (60) days after billed), Relativity may terminate this Agreement by written notice, unless Client pays the full amount claimed within
fifteen (15) days after Relativity delivers such notice. 
 d. Other Violations. If either party violates any provision of this
Agreement other than as provided above, the non-defaulting party may terminate this Agreement effective fifteen (15) days after providing notice of the default to the defaulting party, unless such party
remedies such default within such time period. 
 e. Other Remedies. Termination of this Agreement shall not be in limitation of any
other remedies, subject to Section 13 and the other express provisions of this Agreement. If Client fails to pay any amount when due under this Agreement, Relativity may charge interest of one percent (1%) per month (or any lower rate required
by Laws) on the unpaid amount and suspend any Services or the License, decline to provide Updates or Add-Ons, and/or decline to permit Client to add Additional Named Users until payment is made, without
limiting other rights and remedies. Termination, arbitration, and remedies at law will be inadequate in the following cases, and therefore the parties agree that: (i) each party shall be entitled to seek and obtain immediate injunctive relief
if the other party violates or appears likely to violate the provisions of this Agreement respecting Confidential Information or the provisions in Section 8, and (ii) Relativity shall be entitled to seek and obtain immediate injunctive
relief if Client violates or appears likely to violate this Agreement respecting IP or other rights, or the restrictions set forth in Section 7. 

11. Other Termination Rights; Actions Upon Termination. Upon termination of this Agreement for any reason: (a) all Licenses shall
thereupon terminate; (b) Client will immediately discontinue access to, and use of, the Software; (c) Client shall certify to Relativity in writing within fourteen (14) days the permanent destruction of all Software and all Relativity
Confidential Information; and (d) Relativity may require that Client apply a “kill code” to each instance of the Software and send Relativity a screen shot evidencing the application of the kill code. No refund of any payment will be
made to Client upon early termination, except as expressly provided in this Agreement.  

  
 7 

 12. Notices 

a. Every notice purporting to terminate, exercise any legal right under, or assert any legal claim under, this Agreement shall only be
effective if: (i) such notice is in writing and reasonably refers to this Agreement; and (ii) such notice is delivered in person by a worker or representative of the sending party or local courier service, or sent by a leading overnight
delivery service or email as a pdf attachment, to the other party at the address below (or such other address or contact person as either party may designate by notice as required herein). 

 

					
		 	Client:	  	LDiscovery, LLC
		 		  	Attn: Chris Weiler
		 		  	8201 Greensboro Drive, Suite 300
		 		  	McLean, VA 22102-3810
		 		  	Email: Chris.Weiler@krolldiscovery.com
			
		 	Relativity:	  	Relativity ODA LLC
		 		  	Attn: General Counsel
		 		  	231 South LaSalle St., 8th Floor
		 		  	Chicago, Illinois 60604
		 		  	Email: legal@relativity.com

 b. Each notice shall be deemed delivered: (i) immediately upon delivery in person by a worker or
representative of the sending party or by local courier service; (ii) on the next business day in the recipient’s area if sent by a leading overnight delivery service; or (iii) if made by email, at the time receipt thereof has been
acknowledged by electronic confirmation or otherwise. Written notices which reasonably refer to this Agreement, but are not given pursuant to the other requirements, shall be effective when received by the proper party at the required address.
Written notices which are not given pursuant to the requirements in this Section shall be effective if and when specifically acknowledged by the other party in writing. 

13. Laws and Dispute Resolution. 

a. Laws. Each party shall comply with all federal, state, and local laws, statutes, ordinances, rules, regulations, codes, and
other governmental requirements, and applicable court and administrative decisions, orders and decrees (“Laws”) applicable to such party’s business operations and activities under or in connection with this Agreement.
This Agreement shall be governed by, and interpreted in accordance with, the Laws of the State of Illinois, without regard to any choice of law or conflicts of laws provisions. To the extent that this Agreement permits Client to locate and use any
of the Software outside the United States, such permission is subject to Client procuring any applicable governmental approvals and licenses and complying with any other governmental requirements and procedures, including but not limited to
governmental restrictions on data encryption and the export of technical data. Without limiting the generality of the foregoing provisions, Client shall comply with all export, re-export, and import laws of
the United States and any other applicable countries, obtain all applicable export, re-export, and import licenses, and pay all tariffs, import duties, export fees, and any other levies, imposts, charges,
taxes, and assessments of any kind and nature. Client shall not permit access to the Software or transfer, export or re-export of the Software, or the underlying information or technology, by or to any person
or party who is a national or resident of, or located in, any country on the United States Department of Treasury’s List of Specially Designated Nationals or the U.S. Department of Commerce’s Table of Denial Orders, or any other country
which is subject to restrictions imposed by governmental authority. 

  
 8 

 b. Arbitration. Any claim of damages of any kind by one party against the other
party arising out of or relating to this Agreement, and any dispute or controversy arising out of or relating to such claim or the breach, interpretation or validity of this Agreement or any provision thereof in relation to such claim, shall be
determined by binding arbitration in Chicago, Illinois, before one arbitrator. The arbitration shall be administered by JAMS, The Resolution Experts, pursuant to its Streamlined Arbitration Rules and Procedures in effect at the time;
provided, the arbitrator shall grant reasonable extensions of time if requested. The Award shall be reasoned and in writing. Judgment on the Award may be entered and enforced in any court having jurisdiction. The parties shall bear
their own costs, fees and expenses in arbitrating any dispute, and shall share equally the fees and costs of JAMS and the arbitrator. This clause shall not preclude the parties from seeking provisional remedies in aid of arbitration. No demand for
arbitration may be made more than one (1) year after the event giving rise to the claim occurred or when sooner barred by the applicable statute of limitations or repose. In no event shall any arbitrator have any authority to modify this
Agreement, award any types of damages which the parties have waived, released, or agreed not to assert, under this Agreement, or award any amount which exceeds any limitations contained in this Agreement. The arbitration procedure herein is fully
binding, final, and non-appealable, and constitutes the parties’ only recourse for any claim of damages. 

c. Related Provisions. Notwithstanding anything to the contrary contained in this Agreement, arbitration shall not be required in order
for either party to exercise any specific remedies contained in this Agreement based on a violation by the other party, and either party may pursue court remedies for claims which do not seek to recover damages from the other party, without
submitting such claims to arbitration, and without notice except as required by court procedures. By way of examples, and without limiting the generality of the foregoing statement, either party may: (i) exercise any express right to terminate
this Agreement without being required to arbitrate any dispute or controversy arising out of or relating to such termination; and (ii) pursue actions in court seeking to obtain and enforce declaratory, injunctive or other equitable relief, and
judgments for unpaid fees under this Agreement, or the refund of fees under this Agreement. All claims that are not subject to the above arbitration provisions (including claims that an arbitrator has exceeded his or her authority and claims
involving the determination of the scope or applicability of the foregoing arbitration provisions), shall be litigated exclusively in a federal or state court sitting in Cook County, Illinois; the parties hereby agree that such courts are convenient
forums and submit to the jurisdiction and venue of such courts. The prevailing party in any such litigation shall be entitled to recover its reasonable legal fees and costs from the other party. IN THE INTEREST OF SAVING TIME AND RESOURCES, THE
PARTIES HEREBY MUTUALLY WAIVE ALL RIGHTS TO TRIAL BY JURY IN ANY COURT ACTION, PROCEEDING OR COUNTERCLAIM BROUGHT BY EITHER PARTY AGAINST THE OTHER ARISING OUT OF OR RELATING TO THIS AGREEMENT. Although such jury waiver is intended to be
self-operative and irrevocable, the parties each further agree, if requested, to confirm such waivers in writing at the time of commencement of any such action, proceeding or counterclaim. This Section shall survive termination of this Agreement.

 14. Limitation of Liability. As a material inducement for Relativity to enter into this Agreement, Client agrees, to the fullest
extent not prohibited by applicable Laws, as follows: 
 a. Client agrees: (i) that Relativity is not an insurance company;
(ii) that business interruption insurance, IP infringement insurance, and other coverages are available; (iii) that Relativity’s fees for the Software would be substantially higher if Relativity were to agree to undertake additional
obligations and liabilities than Relativity has expressly undertaken in this 

  
 9 

 
Agreement; and (iv) that Client will look solely to its insurance or self-insurance programs to the extent that any losses, costs, judgments or expenses are not covered by Relativity’s
express obligations and liabilities contained in this Agreement; and Client waives all rights of subrogation of its insurers against Relativity and its affiliates, vendors, and their respective personnel. 

b. IN NO EVENT WILL RELATIVITY OR CLIENT, RELATIVITY’S SUPPLIERS OR LICENSORS BE LIABLE FOR ANY INDIRECT, INCIDENTAL, CONSEQUENTIAL,
SPECIAL, PUNITIVE, EXEMPLARY OR OTHER DAMAGES OR LOSSES (INCLUDING, BUT NOT LIMITED TO, DAMAGES FOR LOSS OF BUSINESS PROFITS, BUSINESS INTERRUPTION, LOSS OF BUSINESS INFORMATION, DATA, GOODWILL OR OTHER PECUNIARY LOSS) ARISING OUT OF THE USE OR
INABILITY TO USE THE SOFTWARE, PROBLEMS WITH THE SOFTWARE, UNAUTHORIZED ACCESS OR HACKING INTO THE SOFTWARE, OR ANY BREACH OF RELATIVITY OR CLIENT’S WARRANTIES OR OBLIGATIONS, EVEN IF SUCH DAMAGES OR LOSSES WERE FORESEEABLE OR RELATIVITY OR
CLIENT HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES OR LOSSES, AND CLIENT AND RELATIVITY WAIVES, RELEASES AND AGREES NOT TO ASSERT ALL SUCH CLAIMS. 

c. IN ANY EVENT, EACH PARTY’S RESPECTIVE AGGREGATE TOTAL MONETARY LIABILITY UNDER ALL CAUSES OF ACTION AND ALL THEORIES OF LIABILITY
(INCLUDING BUT NOT LIMITED TO STATUTORY, TORT, STRICT LIABILITY, WARRANTY, INDEMNITY, CONTRIBUTION, AND CONTRACT THEORIES) WILL BE LIMITED TO AN AMOUNT EQUAL TO THE ANNUAL FEES PAID AND PAYABLE BY CLIENT TO RELATIVITY UNDER THIS AGREEMENT FOR THE
FIRST YEAR OF THE TERM (OR SUCH HIGHER AMOUNT AS MAY BE IN EFFECT FOR ANY SUBSEQUENT YEAR OF THE TERM, PROVIDED THAT THE TOTAL CAP FOR ALL SUCH CLAIMS IN THE AGGREGATE DURING THE TERM SHALL NOT EXCEED ONE YEAR OF FEES AT THE HIGHEST ANNUALIZED
AMOUNT IN EFFECT UNDER THIS AGREEMENT); PROVIDED, THE FOREGOING LIMITATION WILL NOT APPLY TO: (i) EITHER PARTY’S VIOLATIONS OF SECTION 5; (ii) CLIENT’S OBLIGATIONS UNDER SECTIONS 6 OR 7; (iii) RELATIVITY’S OBLIGATIONS UNDER
SECTION 9; OR (iv) FRAUD OR WILLFUL MISCONDUCT. IN ADDITION, CLIENT’S OBLIGATIONS TO PAY FEES UNDER THIS AGREEMENT ARE NOT SUBJECT TO THIS PROVISION AND WILL NOT BE COUNTED TOWARDS THE CAPPED LIABILITY OF CLIENT UNDER THIS PROVISION. 

15. General Provisions 

a. Publicity; Trademarks. Neither party shall use the name, logo or trademark of the other party (or of its third party vendors)
in any press release, advertising or other publicly disseminated document or materials without the written consent of the other party. Each party may list on its web-site, in a professional and reasonable
manner, the other party’s name, logo and trademark while this Agreement is in effect; provided, the listing party shall: (i) comply with all of the other party’s guidelines and requirements for such matters; and
(ii) remove the other party’s name, logo and trademark immediately upon such party’s request. 
 b. Permitted Government
Use. If Client’s customers for the Software include any agency or department of the United States Federal Government (“Government”), the parties agree that this paragraph will apply to the Software and Documentation, and
Client agrees to include provisions corresponding to this paragraph in its agreements with the Government. All Software and Documentation that are provided to the Government are provided with restricted rights as contained in this Agreement. All
use, duplication and/or disclosure by the Government of such Software and Documentation is subject to FAR 52.227-19, “Commercial Computer Software—Restricted Rights”, or DFAR 227.7202-3, “Rights in Commercial Computer Software 

  
 10 

 
or Commercial Computer Software Documentation”, as applicable. Notwithstanding anything to the contrary in FAR 52.227-19, DFAR 227.7202-3 or any other such provision, the Government MAY NOT in any fashion modify, combine with other software products, reproduce and/or distribute, other than as specifically permitted by this License, any
Software or Documentation. The Software and Documentation are “commercial items” as that term is defined in 48 C.F.R. 2.101 (October 1995) consisting of “commercial computer software” and “commercial computer software
documentation” as such terms are used in 48 C.F.R. 12.212 (September 1995). Consistent with 48 C.F.R. 12.212 and 48 C.F.R. 227.7202-1, 227.7202-3 and 227.7202-4 (June 1995), Client or its customer or end user is the Government, the Software and Documentation are licensed hereunder (i) only as a commercial item, and (ii) with only those rights as are
granted pursuant to the terms and conditions of this Agreement. 
 c. Successors and Assigns. As provided in Sections 1 and 7, the
License is not transferable, is not sub-licensable, and is subject to other restrictions. Without limitation as to such provisions, Client shall not, without the prior written consent of Relativity (which
Relativity will not unreasonably withhold, condition or delay), directly or indirectly: (i) assign, mortgage, pledge, encumber, or otherwise transfer, this Agreement, the License, or any interest hereunder, by operation of Law or otherwise; or
(ii) grant any sub-license under the License (all of the foregoing are herein referred to collectively as “Transfers” and any party to whom any Transfer is made or sought to be made is herein
referred to as a “Transferee”). A “Transfer” shall also include: (1) dissolution of Client; (2) merger or consolidation of Client with another party; (3) withdrawal or change of a majority of the partners or
members, or a transfer of a majority of partnership or membership interests, of Client or any parent company in a twelve month period; or (4) the sale or other transfer of more than an aggregate of 50% of the voting shares or net assets of
Client or any parent company in a twelve month period. Subject to the provisions in this Agreement, this Agreement shall be binding on and inure to the benefit of the parties’ successors and assigns. 

d. Authority; Actions of Representatives. Client and all persons signing for Client below, and Relativity and all persons signing for
Relativity below, hereby represent that this Agreement has been fully authorized and no further approvals are required. Each party shall be liable for breach of this Agreement by such party’s Representatives (as defined in Section 5). 

e. Severability. If this Agreement or any phrase or portion of this Agreement is held void, unenforceable, or prohibited by Law, then
this Agreement and any such phrase or portion shall be reasonably reformed (by modifying, adding, or deleting text) to the minimum extent required to carry out the parties’ mutual intent that this Agreement and all phrases and provisions shall
be valid and enforceable to the fullest extent permitted by Law. 
 f. Third Party Beneficiaries. EXCEPT AS EXPRESSLY PROVIDED IN
THIS AGREEMENT, THE PARTIES HEREBY EXPRESSLY DISCLAIM ANY INTENTION TO CREATE ANY THIRD PARTY BENEFICIARIES OF THIS AGREEMENT. 
 g. No
Partnership; Relationship of Parties. The parties are only acting as independent contractors under and in connection with this Agreement. Neither this Agreement nor the actions of any party, nor any statements regarding
“partners” or a “partnership” on Relativity’s web-site, in its marketing materials or other Documentation, or made in any communications between the parties shall be
interpreted as creating an actual or implied partnership, joint venture, agency or other relationship. 

  
 11 

 h. Force Majeure. If the performance of any part of this Agreement by a party
(except Client’s payment obligations) is prevented, hindered, delayed or otherwise made impracticable by conduct of the other party or by terrorism, riot, judicial or governmental action, labor disputes, act of God or any other causes beyond
the reasonable control of the affected party, the affected party shall be excused from such performance, but only to the extent that, and only so long as, it is actually prevented, hindered or delayed by such causes. 

i. No Waiver or Estoppel. No waiver by, or estoppel of, either party respecting any right or provision in this Agreement, including
this no waiver or estoppel paragraph, shall be effective unless expressly set forth in writing and signed by an authorized representative of such party. Without limiting the generality of the foregoing: (i) no act, failure to act, payment,
acceptance of payment, or course of dealing, including any failure or delay in billing Client for taxes or any other amounts that Client is required to pay, shall create a waiver or estoppel, regardless of how long it continues; and (ii) no
failure to exercise, nor any delay in exercising, on the part of either party, any right or remedy hereunder shall operate as a waiver of, or estoppel to assert, such right or remedy, nor shall any single or partial exercise of any right or remedy
prevent any further or other exercise thereof or the exercise of any other right or remedy. Any waiver or estoppel respecting any right or provision on any occasion or occasions shall not be a waiver or estoppel respecting such right or provision on
any future occasion. 
 j. Survival and Acceleration. Termination of this Agreement shall not relieve either party from liability for
any violation occurring prior to such termination, subject to the other provisions of this Agreement. ANY PAYMENT OBLIGATION THAT WOULD OTHERWISE ACCRUE AFTER TERMINATION OF THIS AGREEMENT BY RELATIVITY BASED ON A CLIENT DEFAULT SHALL BECOME DUE AND
PAYABLE UPON SUCH TERMINATION. Any provisions of this Agreement that expressly provide, or by reasonable implication are intended, for survival after termination shall remain in effect in accordance with their terms. 

k. Interpretation; Language Choice. Unless the context of this Agreement clearly requires otherwise: (i) the word
“party” shall include individuals, corporations, partnerships, limited liability companies, and other entities; (ii) the singular shall include the plural, and the plural shall include the singular; (iii) the words
“includes” and “including” shall mean “including without limitation;” (iv) the word “or” shall mean “and/or;” and (v) words such as “hereof,” “herein,” “hereunder,”
and similar words refer to this Agreement as a whole and not any particular section in which such words appear. In interpreting any vagueness or ambiguity, captions shall not be used and no presumption shall apply against the party preparing this
Agreement. Under no circumstances will the “Uniform Computer Information Transactions Act,” the American Law Institute’s “Principles of the Law of Software Contracts,” as model laws or as adopted in any jurisdiction, or the
United Nations Convention on Contracts for the International Sale of Goods, or similar acts, laws and conventions have any bearing on the interpretation or enforcement of this Agreement and the parties hereby elect to opt out of all such acts, laws
and conventions. The parties hereby confirm that they have requested that this Agreement and all related documents be drafted in English. Les parties ont exigé que le présent contrat et tous les documents connexes soient
rédigés en anglais. 
 l. Whole Binding Agreement; Amendments; Counterparts; Electronic Delivery. THIS AGREEMENT:
(i) SHALL BE BINDING, AND MAY BE AMENDED, ONLY IF AND WHEN A FORMAL AMENDMENT IS SIGNED AND DELIVERED BY BOTH PARTIES IN THE MANNER PERMITTED HEREIN, AND (ii) MAY NOT BE AMENDED ORALLY OR BY COURSE OF CONDUCT OR DEALING. If Client issues
any purchase order, receipt or other documentation, such items shall be deemed to be solely for the administrative convenience of Client and shall not be binding or serve to modify or supplement this Agreement, even if signed or processed by
Relativity. This Agreement and the Exhibits constitute the entire agreement between the parties and supersede all other written and oral representations, proposals, 

  
 12 

 communications and agreements, if any, relative to the subject matter hereof. Any facts or matters thought
by either party to be material to the performance of or inducement into this Agreement are contained herein. The parties may sign and deliver this Agreement or any amendment as complete documents or in separate counterparts (which shall constitute
one agreement), and either party may deliver the same as a pdf by email. Either party delivering by email shall also deliver an ink-signed original promptly upon request; provided, any failure to deliver an ink-signed original shall not affect the
validity of this Agreement or give rise to any remedy except specific performance of such delivery requirement. 
 IN WITNESS WHEREOF, the
parties have caused this Agreement to be executed by their respective duly authorized officers or representatives, as of the Effective Date. 
  

									
	Relativity ODA LLC	 		  	LDiscovery, LLC
					
	By:	 	 /s/ Keith Lieberman
	 		  	By:	  	 /s/ Daniel Zambito

	Name:	 	Keith Lieberman	 		  	Name:	  	Daniel Zambito
	Title:	 	Chief Accounting Officer	 		  	Title:	  	SVP, Legal Technologies

  
 13 

 EXHIBIT A 

SUMMARY OF INITIAL BUSINESS TERMS 

This Exhibit A contains a summary of key business terms of this Agreement which are further explained in Exhibit B. This Exhibit A should
be read with the other Exhibits and other portions of this Agreement. All Exhibits are cumulative with, and supplement, each other and the other provisions of this Agreement. However, in case of express conflict, this Exhibit A governs over
the other Exhibits, and all Exhibits govern over the other portions of this Agreement. 
 Client Name: LDiscovery, LLC 

Term: Three (3) years commencing on the Effective Date at the beginning of this Agreement. 

Relativity Review & Production - Relativity Analytics Licensed Separately 

Named User Cap: [****] Named Users 

Relativity Review Annual Fee: $[****] 

Extra Users Fee: $[****] per month per Extra User in excess of the Named User Cap (See Exhibit B) 

Future increase in the Annual Fee to add a 25 pack of Additional Named Users: $[****] 

Relativity Analytics – Separate from Relativity Review 

Analytics Volume Based Subscription Level (GB): [****] 

Analytics Annual Subscription Fee: $[****] 

Analytics Burst Fee: $[****]/GB 

Pay As You Go Fee: $[****]/GB 
 Relativity
Processing 
 Number of Processing Workers included with the Relativity Review Annual Fee (No Separate Additional Charge): [****]

 Number of Extra Processing Workers (for Extra Processing Worker Annual Fee): N/A 

Total Extra Processing Worker Annual Fee based on Extra Processing Workers licensed above: N/A 

Future increase in the Annual Fee to add Extra Processing Workers: See Exhibit B 

Relativity Data Grid 
 Number of Data Grid
Nodes included with the Relativity Review Annual Fee: [****] 
 Number of Extra Data Grid Nodes (for Extra Data Grid Annual Fee): N/A 

Extra Data Grid Annual Fee for the Extra Data Grid Nodes licensed above: N/A 

Future increase in the Annual Fee to add Extra Data Grid Nodes: $[****] per Data Grid Node per Year 

  
 14 

 Relativity Legal Hold 

Number of Permitted Active Holds: [****] 

Legal Hold Annual Fee: $[****] 
 Production
Instances: 
 Number of Production Instances included with Relativity Review Annual Fee: [****] 

Number of Free Extra Production Instances: [****] 

Number of Extra Production Instances (for Extra Production Instance Annual Fee): [****] 

Extra Production Instance Annual Fee for the Extra Production Instances licensed above: $[****] 

One Year Production Instances 
 Number of
One Year Production Instances: One (1)* 
 One Year Production Instance Annual Fee for the One Year Production Instances licensed above: N/A*

  

	*	 In the Eighteenth Amendment to the Kroll Agreement, Relativity granted Kroll a license to deploy a One Year
Production Instance (“Existing One Year Instance”), which was subsequently extended for an additional one (1) year period in the Twenty Seventh Amendment to the Kroll Agreement. The Existing One Year Instance shall
remain in effect until its scheduled expiration date of July 20, 2018, subject to any additional one year extensions. 

 Temporary
Production Instances 
 Number of Temporary Production Instances: [****] 

Temporary Production Instance Monthly Fee for the Temporary Production Instances licensed above: $[****] per calendar month (fees not included
in the Total Initial Annual Fees below) 
 Temporary Production Instance Named User Fee: $[****] per Named User per Temporary Production
Instance in any given month (See Exhibit B) 
 Relativity Client Domains 

Number of Client Domain Tenant Accounts (for Client Domain Annual Fee): [****] 

 

			
	 •  Client Tenant Account 1:
	  	 [****]

		
	 •  Client Tenant Account 2:
	  	 [****]

		
	 •  Client Tenant Account 3:
	  	 [****]

 Client Domain Annual Fee for the Client Domain Tenant Accounts granted to Client above: $[****] 

TOTAL INITIAL ANNUAL FEES PER ABOVE: 
  

					
	Year 1	  	Year 2	 	Year 3
	 $[****] minus the Prepay Credit described below
	  	$[****]	 	$[****]

  
 15 

 Prior License Agreement and Kroll Agreement Prepay Credit. This Agreement supersedes and replaces the
“Prior License Agreement” and the “Kroll Agreement” (collectively the “Superseded Agreements”), as described in the Background section at the beginning of this Agreement. As further described in such Background
section, Client will remain liable to pay any amounts due under the Superseded Agreements accruing or arising prior to the Effective Date hereof, whether or not already billed, and Relativity will provide Client with a prorated credit for the
prepaid amounts under the Superseded Agreement (“Prepay Credit”), which is comprised of: 
  

	 	•	 	 $[****] for the prepaid amounts under the Prior License Agreement; plus

  

	 	•	 	 $[****] for the prepaid amounts under the Kroll Agreement; plus 

 

	 	•	 	 A prorated credit for the RA Subscription Fee for the RA Subscription granted to Client in the Ninth Amendment to
the Prior License Agreement, that is the lesser of: (a) $[****] per GB for any unused Relativity Analytics GBs as of the Effective Date of this Agreement; or (ii) $[****], which is the prepaid portion of the LDiscovery RA Subscription Fee prorated
for the period from the Effective Date hereof to September 30, 2018; plus 

  

	 	•	 	 A prorated credit for the Analytics Annual Subscription Fee for the Analytics Volume Based Subscription granted
to Kroll in the Twenty Ninth Amendment to the Kroll Agreement, that is the lesser of: (a) $[****] per GB for any unused Relativity Analytics GBs as of the Effective Date of this Agreement; or (ii) $[****], which is the prepaid portion of the Kroll
Analytics Annual Subscription Fee prorated for the period from the Effective Date hereof to September 30, 2018. 

 ANNUAL
PAYMENT DATES:
 The above Annual Fees for the first 12-months of the Term are due on the Effective Date in
the beginning of this Agreement. The subsequent Annual Fees are due and payable on the 12th month and 24th month anniversaries of the Effective
Date; provided (a) Relativity will use reasonable efforts to deliver an invoice between thirty (30) and sixty (60) days in advance; and (b) in no event will the Annual Fee be due sooner than thirty (30) days after Relativity
delivers the invoice. 
 Client Billing Contact and Cycle. Unless Client directs otherwise, Relativity will send bills to: 

LDiscovery, LLC  
 Attn:
Dawn Wilson, CFO 
 8201 Greensboro Drive, Suite 300 

McLean, VA 22102-3810 
 Email:
dawn.wilson@krolldiscovery.com 
 For any amounts payable by Client for which the timing of the payment is not otherwise specified in this Agreement,
Relativity will generally bill Client at about the close of each month, and payment is due thirty (30) days after the amount is billed. Relativity may send bills via email. 

Taxes. All amounts under this Agreement are exclusive of any applicable Taxes. Except for taxes based on Relativity’s net income, Client shall pay
all applicable sales, use, excise, valued-added or other tax, fee or duty levied by federal, state and local governments in connection with this Agreement, the License or Services and/or any payment made by Client hereunder
(“Taxes”). Relativity shall bill Client for any applicable Taxes to the extent that applicable laws impose collection obligations on Relativity as the licensor of commercial software (which is delivered over the Internet and
deployed by Client behind its firewall) and as the provider of related software support Services. Relativity shall have discretion to defer any remittance, and any invoicing of Client, of any Taxes so long as Relativity believes there may be a
lawful basis to dispute or contest such Taxes. If Relativity does so, and if Relativity eventually determines that it needs to pay such Taxes, Relativity may invoice the deferred amounts and Client shall pay such invoices; provided,
Relativity will not invoice Client for, and agrees to indemnify and hold Client harmless from and against, any penalties and interest assessed based upon Relativity’s failure to remit, or delay in remitting, Taxes in accordance with this
Section. 

  
 16 

 EXHIBIT B 

ADDITIONAL LICENSING PROVISIONS AND RELATED TERMS 

DEFINITIONS. The following terms shall have the meanings ascribed thereto when used as capitalized terms in the other provisions of this
Agreement and Exhibits: 
 “Documentation” means printed material associated with, provided with, or provided by the
Software, including the description of the principles of operation. 
 “Intellectual Property Rights” or
“IP” means any and all rights arising from or under any of the following, whether protected, created or arising under the laws of the United States of America or any other jurisdiction: patents (including, but not limited to, any
applications, extensions, divisions, continuations, continuations-in-part, reexaminations, reissues, and renewals related thereto), copyrights (including, but not
limited to, any applications, registrations and renewals related thereto), trademarks and service marks (including, but not limited to, applications, registrations, and renewals related thereto), trade dress, trade names, trade secret and know-how and any other intellectual property or proprietary rights of any nature, by whatever name or term known or however designated. 

“Software” means the software programs created by Relativity and supplied under this Agreement or any subsequent
amendment or order, all Updates and any Add-Ons (if Client pays for an Add-On) supplied by Relativity to Client under this Agreement. Software may include embedded third
party programs which shall be subject to the provisions of this Agreement. 
 “Update” means any modification, revision, or
other enhancement, to the Software created by Relativity during the Term of this Agreement, other than Add-Ons (unless Client pays for an Add-On), but including
Corrections, Minor Updates, Minor Releases, Critical Patch Releases, and Major Releases, as such terms are defined in Exhibit C to this Agreement. Relativity may, at its option, include in any Update any item that was previously available as
an Add-On. 
 SOFTWARE USE AS HOSTED SERVICE. Client shall only use and permit the Software to be used
by Client’s customers on a hosted basis as part of Client’s e-discovery litigation support services. 

USAGE REPORTING. Client’s billing and usage data will be delivered to Relativity through the Software in accordance with the applicable
Documentation. Relativity has provided an optional feature in the Software by which Client may choose to obfuscate case names and/or the client or matter names and/or the personal name portion of the email address used for Named User log-ins. If Client uses that obfuscation feature and is licensing more than one Production Instance of the Software, Relativity may require that Client consistently uses the obfuscation feature in all Production
Instances in order to handle billing determinations consistently. In such cases, Client shall provide such additional information, upon request, as may be necessary for Relativity’s billing and auditing purposes. Upon Relativity’s requests
from time to time, Client shall also cooperate in: (a) applying, running and providing the results of special usage and billing scripts for given products; (b) providing Relativity and its representatives with certifications respecting
Named Users and usage metrics, and (c) granting remote supervised secure access to the Software for Relativity to verify billing and usage information. 

SOFTWARE EXCLUSIONS. This Agreement does not include any other licenses that are required to run the Software, including Microsoft Windows
Server, Microsoft’s SQL Server database server, and any other third party products that may otherwise be system requirements. 
 RELATIVITY
REVIEW & PRODUCTION 
 Relativity Review & Production - Overview and Deployment Limitations: 

• “Relativity Review & Production” is sometimes referred to as “Relativity
Review” for short. Relativity Review includes highly scalable document review capabilities, document production functions, and numerous additional features and functions described further on the Relativity website. 

  
 17 

 • “Relativity Server Software” is the main component of
Relativity Review which Client may install on an unlimited number of Network Server Computers in Client’s Computer Network, provided Client shall only deploy the Server Software behind Client’s firewall at Client’s site or in a cloud
data center. 
 • “Relativity Web Client” is any ancillary required component that Client may deploy on an
unlimited number of computers in Client’s Computer Network and any end users’ computers at the sites of Client, Client’s bona fide direct customers for e-discovery litigation support services
and Client’s consultants in support of Client’s business operations (and Client may permit such end users to use the Software for such purposes as permitted under this Agreement). With Relativity 9.3 and higher, the Client Software is not
required for ordinary use of the Software, but instead contains miscellaneous additional administrative tools, such as Relativity Desktop Client (RDC) and Database Management Tool (DBMT), and the optional use of Native Document Viewer. 

• “Client’s Computer Network” means any combination of two or more terminals or computers that are
electronically linked and capable of sharing the use of a single software program and that are owned and operated by Client. Client’s Computer Network includes remote terminal access by Client’s end users as permitted herein. 

• “Network Server Computer(s)” means any server(s) in Client’s Computer Network. 

NAMED USER CAP; MONTHLY EXTRA USERS; ADDING USER PACKS 

Named User Cap. Client’s License for the Relativity Review Software is limited to the number of Named Users in the Named User Cap
set forth in Exhibit A. Relativity will bill Client the amount of the Extra Users Fee set forth in Exhibit A times the number of Extra Users in any month. 

“Extra Users” means, in any month, the total number of Named Users minus the Named User Cap, as set forth in Exhibit
A. “Named Users” means the number of individuals (including Client’s systems and support administrators) who are given access (also called “enabled”) to use the Software within the month in question, regardless of
any actual use, or duration or frequency of use, and regardless of whether any such individual’s access is terminated (also called “disabled”) before the month ends. 

Additional Named Users and Fees. Client may, by written agreement with Relativity, add “Additional Named
Users” in 25-user increments to the Named User Cap for the increase in the Annual Fee set forth in Exhibit A. For Additional Named User increments added part way through a year of the Term,
Relativity will prorate the payment for the added increment(s) for the partial year as of the first day of the month in which the addition is made, and will bill the amount when the agreement respecting such addition is signed. Thereafter, Client
will pay the additional amount for the Additional Named Users each year in advance as an increase in the Annual Fee. Additional Named Users cannot be added when there are fewer than twelve (12) months remaining in the Term. 

Aggregating Named Users. If Client is ever licensing more than one Production Instance under this Agreement, the number of Named Users
for each Production Instance shall be aggregated and counted together for purposes of billing Extra User Fees for any Extra Users, excluding any Production Instance which is not licensed co-terminously with the Term of this Agreement (unless the
licensing provisions for such non-coterminous Production Instance specifically provide for aggregating the Named Users with the Named Users of other Production Instances under this Agreement). However, this
Section is not intended to require that the same individual who is enabled to use more than one such Production Instance during a given calendar month be counted more than once in determining Extra Users. Relativity will use reasonable efforts to
aggregate and de-duplicate Named Users across the Production Instances and then bill Client only based on the unique Named Users. If Client determines that Relativity double-charged for Extra Users, e.g. as a
result of one or more Named Users being counted in more than one Production Instance during the same month, Client may bring such charges to Relativity’s attention promptly in writing. In such case, Relativity shall reasonably review such
charges and applicable supporting data or information, and provide appropriate credits. 

  
 18 

 RELATIVITY ANALYTICS 

Relativity Analytics - Functions Overview

• Relativity Analytics includes various functions that involve building a data index, including functions for clustering, concept
searching, keyword expansion, and similar document detection. 
 • Relativity Analytics includes other functions that use structured
data analytics tools, including functions for email threading, textual near duplicate identification, and language identification. 
 •
Relativity Analytics can also be used with Relativity Assisted Review, which is a technology-assisted review program (sometimes referred to as TAR or predictive coding).  

Relativity Analytics - Fees Overview 

• Relativity Review with Unlimited Relativity Analytics. If Exhibit A includes Relativity Review with Unlimited
Relativity Analytics, the included Relativity Review Annual Fee includes and permits an unlimited amount of Relativity Analytics use by Client, subject to the applicable terms of this Agreement. 

• Relativity Analytics Volume Based Subscription Level (GB). If Exhibit A includes a Relativity Analytics Volume
Based Subscription Level (GB), a Client will initially pay the Analytics Annual Subscription Fee in Exhibit A, and then make elections and pay as provided below. 

• Relativity Analytics
Pay-As-You-Go. If at any point Client does not have a Relativity Analytics Volume Based Subscription Level or a license
to use an unlimited amount of Relativity Analytics, Client may use Relativity Analytics by paying Relativity Analytics Pay As You Go Fees with usage billed at the end of each month at the rate in Exhibit A and as described below. In addition,
Client may obtain a Relativity Analytics Volume Based Subscription Level (GB) by signing Relativity’s confirmatory amendment or other such document and paying the applicable Analytics Annual Subscription Fee. 

Relativity Analytics - Volume Based Subscription Fees 

• Relativity Analytics annual subscriptions have a data usage threshold. The annual fee covers all data usage up to the threshold during
the annual period. Usage is measured based on the total size of the native files evaluated by Relativity Analytics. Documents are evaluated by Relativity Analytics, when a search is created, and the results of that search are added to a Relativity
Analytics index or otherwise have a Relativity Analytics feature run against them. 
 • If the data threshold is surpassed during the
annual period, monthly burst fees apply based on an amount per GB until the end of the 12-month period per the schedule below. There is no carryover of any unused portion of the threshold once the annual
period expires, at which point a new annual subscription can be purchased if the license agreement is still in effect. 
 • Relativity
Analytics subscriptions are available in different pricing packages based on the amount of data usage as set forth in the schedule below. During any period when Client does not have a Relativity Analytics subscription in effect under this Agreement,
Relativity may use Relativity’s then current Relativity Analytics standard subscription fee schedule if Client desires to add an analytics subscription. 
  

									
	 Annual Subscription
	  	Data Threshold	 	  	Analytics Burst Fee	 
	 $[****]
	  	 	500 GB	 	  	$	[	****]/GB 
	 $[****]
	  	 	1,000 GB	 	  	$	[	****]/GB 
	 $[****]
	  	 	4,000 GB	 	  	$	[	****]/GB 
	 $[****]
	  	 	15,000 GB	 	  	$	[	****]/GB 
	 $[****]
	  	 	30,000 GB	 	  	$	[	****]/GB 
	 $[****]
	  	 	50,000 GB	 	  	$	[	****]/GB 

  
 19 

 Relativity Analytics - Measuring Data Usage 

• All Analytics pricing schedules measure usage based on the total size of the native files evaluated by Relativity Analytics. Documents
are evaluated by Relativity Analytics when a search is created and the results of that search are added to a Relativity Analytics index or a Structured Analytics Set, or the search results are otherwise submitted to a Relativity Analytics feature.
The size of the native file is measured for billing if a document has a native file link. If a document does not have a native file link, the document count is converted to a per GB measurement for billing, as follows: 

 

	 	•	 	 If a document doesn’t have a native file or a TIFF link (e.g. text only), the document count is converted to
GB at 4,000 docs / GB. For example if you use any feature of Relativity Analytics to evaluate 80,000 documents that had neither a native file link or an image link, your usage level would be calculated as 20 GB: [80,000 text only documents / 4,000
docs / GB]. 

  

	 	•	 	 If a document doesn’t have a native file link, but has a TIFF link, the document count is converted to GB at
11,750 docs / GB. For example if you use any feature of Relativity Analytics to evaluate a total of 150 GB of native files and 7,050,000 non-native documents with images only in Analytics, your usage level
would be calculated as 750 GBs: [150 GB native + (7,050,000 non-native documents / 11,750)]. 

• If Client ever has a Relativity license for more than one Production Instance of the Relativity Software, and also has an annual
Relativity Analytics subscription, the Relativity Analytics data usage is aggregated across the Production Instances (including Temporary Production Instances), unless Client elects to pay for separate Relativity Analytics subscriptions for each
Production Instance or elects “Pay As You Go” pricing for other Production Instances. 
 RELATIVITY PROCESSING 

Relativity Processing - Functions Overview 

• Relativity Processing converts many native file types into formats for review in Relativity Review. Features include metadata and
container extraction, domain parsing, and native application imaging. 
 • An inventory stage provides quick insight into processing
sets and allows the user to filter out junk before fully processing files. 
 • Relativity Processing is powered by Relativity’s
“Invariant” software engine. More details are described on the Relativity website and in the Documentation. 
 Relativity Processing - Fees
Overview: Included with Relativity Review Annual Fee and Extra Processing Workers 
 • Processing Workers included with
Relativity Review. By specifying a number of Processing Workers that are included in the Relativity Review Annual Fee, Client is licensed to use up to that number of Processing Workers at any time without additional fees for such Processing
Workers. 
 • Extra Processing Workers. To the extent that Exhibit A specifies that Client is licensing and paying
for a stated number of Processing Workers apart from any Processing Workers included with Relativity Review (or if Client hereafter adds more Processing Workers), Client will pay the applicable Extra Processing Worker Annual Fees as set forth in
Exhibit A, or as provided below. 
 Relativity Processing - Annual Fees for Extra Processing Workers 

• Client may periodically add licenses for Processing Workers. To do so: (a) a Client Designated Support Administrator must deliver
an email to sales@relativity.com stating the number of additional Processing Workers and date for adding the Processing Workers, and (b) Client will sign Relativity’s confirmatory amendment or other such document if Extra Processing
Worker Annual Fees are required.     
 • If Client adds Processing Workers that are not included in Exhibit
A, the Extra Processing Worker Annual Fee is based on the following fee schedule and number of Processing Workers licensed (with any Processing Workers in Exhibit A counted towards the number of Total Processing Workers). 

  
 20 

 • Separate Relativity license keys may be required to enable or increase the number of
licensed Processing Workers. The license and payment requirements for each licensed Processing Worker will remain in effect for the remaining Term of this Agreement. 
  

			
	 Total Processing Workers
	  	Relativity Processing Annual Fee
Per Processing Worker
	 Two to Nine
	  	$[****]Each
	 Ten to Nineteen
	  	$[****]Each
	 Twenty to Twenty-Nine
	  	$[****]Each
	 Thirty to Thirty-Nine
	  	$[****]Each
	 Forty to Forty-Nine
	  	$[****]Each
	 Fifty or More
	  	$[****]Each

 • The Relativity Processing Annual Fee is due and payable each year in advance on the same date when the
Relativity Review Annual Fee is due under this Agreement. If Client adds a Processing Worker other than on the regular due date for Relativity Review Annual Fee under this Agreement, Client will pay Relativity, when the Processing Worker is added, a
prorated Relativity Processing Annual Fee for the period from that date to the next Relativity Review Annual Fee due date. 
 • If
Client is ever licensing more than one (1) Production Instance of Relativity’s Relativity Software under this Agreement, the number of licensed Processing Workers will apply in the aggregate across Production Instances, excluding any
temporary Production Instance, i.e. which is not licensed co-terminously with the Term of the Agreement and which shall exclude Relativity Processing (unless the agreement licensing such temporary Production Instance expressly provides to the
contrary). 
 RELATIVITY DATA GRID 

Relativity Data Grid - Functions Overview 

• Data Grid is a NoSQL product that helps index and organize data such as extracted text and audit records. Data Grid can display a
comprehensive, interactive audit history. 
 • The longer term anticipated benefits of using Data Grid include a reduction in SQL
Server database sizes and reduced memory requirements. Not all Relativity Software functions are integrated with Relativity Data Grid at this time, and some functions may require some use of SQL Server indefinitely. 

• Although the Data Grid Documentation will provide more information concerning infrastructure and system requirements, Client
acknowledges that Client will promptly need to upgrade at least to Relativity 9.5, and apply all subsequent Patch Releases, in order to use Relativity Data Grid. 

• Once Client enables a field’s access to Data Grid, Client cannot disable it, so it is important to understand the benefits and
limitations of allowing fields to access Data Grid in new workspaces. Reviewing and understanding all Documentation and training materials is critical. 

  
 21 

 Relativity Data Grid - Fees Overview: Included with Relativity Review Annual Fee and Extra Relativity
Data Grid Nodes 
 • Relativity Data Grid Nodes included with Relativity Review. By specifying a number of Data Grid
Nodes that are included in the Relativity Review Annual Fee, Client is licensed to use up to that number of Data Grid Nodes at any given time without additional fees for such Data Grid Nodes. 

• Extra Relativity Data Grid Nodes. To the extent that Exhibit A specifies that Client is licensing and paying for a
stated number of Data Grid Nodes apart from any Data Grid Nodes included with Relativity Review (or if Client hereafter adds more Data Grid Nodes), Client will pay each year in advance the applicable Relativity Data Grid Node Annual Fees if set
forth in Exhibit A or otherwise based on Relativity’s standard charges for comparable customers at the time. The license and payment requirements for each licensed Data Grid Node will remain in effect for the remaining Term of this
Agreement. IF CLIENT ADDS A DATA GRID NODE WITHOUT CONTACTING RELATIVITY AS OUTLINED BELOW, CLIENT SHALL BE DEEMED TO HAVE LICENSED SUCH NODE(S) AND WILL BE OBLIGATED TO PAY: (i) A PRORATED PORTION OF THE APPLICABLE EXTRA DATA GRID ANNUAL FEE
FOR THE EXTRA DATA GRID NODE(S), PRORATED FROM THE END OF THE MONTH IN WHICH CLIENT ADDS THE NODE(S) TO THE NEXT ANNUAL PAYMENT DATE; AND (ii) THE FULL EXTRA DATA GRID ANNUAL FEE FOR THE NODE(S) FOR THE REMAINDER OF THE TERM OF THIS AGREEMENT.

 Relativity Data Grid - Other Provisions 

• Client can configure Data Grid with various types of nodes, including data nodes, master nodes and client nodes. By default, each node
is considered to be a data node, unless Client turns off the data function. Relativity uses the term “Data Grid Node” in this Agreement to mean data nodes. 

• Client may periodically add licenses for additional Data Grid Nodes. To do so: (a) a Client Designated Support Administrator must
deliver an email to sales@relativity.com stating the number of additional Data Grid Nodes and date for adding the Nodes, and (b) Client will sign Relativity’s confirmatory amendment or other such document if Extra Data Grid Node
Annual Fees are required. The license and payment requirements for Data Grid Nodes will remain in effect for the remaining Term of this Agreement. 

• The Extra Data Grid Node Annual Fee is due and payable each year in advance on the same date when the Relativity Review Annual Fee is
due under this Agreement. If Client adds an Extra Data Grid Node other than on the regular due date for Relativity Review Annual Fee under this Agreement, Client will pay Relativity, when the Extra Data Grid Node is added, a prorated Extra Data Grid
Node Annual Fee for the period from that date to the next Relativity Review Annual Fee due date. 
 • If Client is ever licensing more
than one (1) Production Instance of Relativity’s Relativity Software under this Agreement, the number of licensed Data Grid Nodes will apply in the aggregate across the Production Instances, unless Relativity and Client enter into an
amendment or other documentation allocating Data Grid Nodes to one or more particular Production Instances and requiring Extra Data Grid Node Annual Fees for the deployment of Data Grid Nodes in other Production Instances. 

• Relativity Data Grid is powered by Elasticsearch open source technology as its underlying architecture. Relativity may include with
Relativity Data Grid, or otherwise provide access to, one or more proprietary products created by Elasticsearch, Inc. (“Elasticsearch Proprietary Products”), including products known as Marvel and Shield. Relativity reserves
the right to discontinue its inclusion, use of, or access to, any or all Elasticsearch Proprietary Products at any time. Client may be able to license Elasticsearch Proprietary Products directly from Elasticsearch, Inc. or its successor, and may be
able to obtain other open source and proprietary add-on products from other vendors. If Client incurs costs to obtain Elasticsearch Proprietary Products or any other products directly from Elasticsearch or any
other vendor, Client will still be required to pay Relativity all fees incurred under this Agreement. 

  
 22 

 RELATIVITY LEGAL HOLD 

Relativity Legal Hold - Functions Overview 

• Legal Hold provides an automated system to create and track litigation hold notices, custodian survey questions and custodian responses,
from a library of templates that Client can create and customize. Client set up reminder notices to go out automatically on a scheduled basis. 

• Legal Hold can be integrated with MS Exchange servers to import Client’s personnel efficiently.
Built-in reports and dashboards show the status of your legal holds at a glance, allow you to track and analyze responses, and help you ensure compliance for your organization. 

• Client may use Legal Hold for other projects, such as notifying personnel about an updated Employee Handbook, or Anti-Corrupt Practices
Policy, posted on the company’s intranet, and requiring for confirmations that personnel have reviewed and will comply. 
 Relativity Legal Hold
– Licensing and Fees 
 • If Exhibit A includes Legal Hold, Client will pay the Legal Hold Annual Fee in Exhibit
A. If Exhibit A does not include Legal Hold Client may obtain a license to add Legal Hold to this Agreement by signing Relativity’s confirmatory amendment or other such document and paying Relativity’s standard Legal Hold Annual
Fee then in effect. The license and payment requirements for Legal Hold will remain in effect through the Term of this Agreement. 
 •
The Legal Hold Annual Fee is due and payable each year in advance. If Client begins a Legal Hold subscription on any day that is not the same dates when the Relativity Review Annual Fee is due, Client will pay a prorated amount of the Legal Hold
Annual Fee for a partial annual period to make the Legal Hold subscription run to the date when the Relativity Review Annual Fee is due. 

• The Legal Hold Annual Fee permits Client to have up to the number of Permitted Active Holds identified on Exhibit A (or any
subsequent amendment adding Legal Hold) in effect at any given time. Client’s Legal Hold Administrators will have the ability to close a hold within Legal Hold. A “Permitted Active Hold” is any matter that Client creates in the
Relativity Legal Hold workspace in the Relativity Software until Client uses the function to close the matter. Closed holds will not count against the number of Permitted Active Holds. 

• Each person who is enabled to use Legal Hold will be counted as a Named User of the Relativity Software under this Agreement,
regardless of any actual log-in or use of any Relativity Software product, or the duration or frequency of use during a given month; however, persons who respond to hold notices and questionnaires as
custodians will not count as Named Users. 
 • Client must set up one dedicated workspace in one (1) Production Instance of the
Relativity Software to use Legal Hold exclusively, unless Client obtains a written license for expanded use. If Client ever has a Legal Hold license for more than one (1) workspace and/or Production Instance of the Relativity Software, the
number of Permitted Active Holds will be aggregated across all workspaces and Production Instances under this Agreement, unless the license provides otherwise.  

SOFTWARE PRODUCTION, TEST, AND BACK-UP INSTANCES 

Production Instances
 • A
“Production Instance” is an instance of the Software that: (a) may be used for active cases and investigations, and (b) may consist of any number of physical and virtual server components that all link back to one
set of the Server Software files located on one server. 
 • Instance Settings. Every Production Instance of the Software is
automatically configured to reflect Relativity’s recommended Production Instance settings (“Instance Settings”); however, Relativity may provide Client with the ability to modify certain Instance Settings.
Notwithstanding the foregoing, there are several Instance Setting entries that should never be modified in Client’s Production Instance (“Restricted Instance Settings”), which Relativity identifies by including a
“Do not modify” statement at the beginning of the Instance Setting Description in the Documentation. Relativity strongly discourages the modification of the Restricted Instance Settings due to elevated security risks, among other
things, associated therewith. If Client modifies any of the Restricted Instance Settings, 

  
 23 

 Client (a) may create a security vulnerability in the applicable Production Instance of the Software or
otherwise interfere with the Software’s proper functioning, and (b) will automatically void any applicable warranties offered by Relativity to the extent that Client’s modification of any Restricted Instance Settings causes such
warranties to be breached or inaccurate. Furthermore, Relativity will not be obligated to provide the Maintenance Support Services described in Exhibit C if Relativity reasonably determines that the issue is attributable to the modification
of one or more Restricted Instance Settings. 
 • The License under this Agreement allows Client to deploy and use on Client’s
Computer Network the number of Production Instances set forth in Exhibit A. Client may add one or more Extra Production Instances of the Relativity Software by paying Relativity’s applicable fees and signing Relativity’s standard
amendment. Any other instances are subject to such additional agreements and fees as the parties agree upon in writing. 
 •
Notwithstanding anything to the contrary herein that prohibits the deployment of the Relativity Server Software to any Network Server Computer not located behind Client’s firewall at Client’s site or in a cloud data center or collocation
facility of a third party, Relativity hereby agrees that Client may deploy the Relativity Server Software for any Extra Production Instance as a series of individual temporary mobile deployments behind the firewalls of Client’s customers for
use as part of Client’s e-discovery services (“Mobile Instance Use”), subject to the following provisions: 

• The Server Software for Mobile Instance Use must be: (i) deployed on a server that Client owns and temporarily locates behind its
customer’s firewall (rather than, for example, on hardware that Client’s customer owns); and (ii) restricted to Client’s use in providing e-discovery services to such customer on whose
premises such server is located. 
 • Mobile Instance Use must be project specific and temporary, which means that each deployment will
be limited to one case. 
 • Mobile Instance Use is limited to Client’s bona fide direct corporate customers which require that a
temporary instance of the Software be deployed behind their firewalls for security reasons (or to use Relativity Processing if Client is licensing such Software product under this Agreement). The Extra Production Instance shall not be deployed on
the premises of any law firm or other litigation services company. 
 • For Mobile Instance Use, the Designated Application Support
Administrators must be limited to Client’s own well-qualified employees who are the Designated Application Support Administrators under this Agreement (and shall not, for example, include any of Client’s customers’ personnel). 

One Year Production Instances 
 • A
“One Year Production Instance” is a Production Instance of the Software, and related deployments of the Web Client Software, that may be deployed for a period of twelve (12) months. 

  
 24 

 • The License under this Agreement allows Client to deploy and use on Client’s
Computer Network the number of One Year Production Instances set forth in Exhibit A. Client may add one or more additional One Year Production Instances, by paying Relativity’s applicable fees and signing Relativity’s standard
amendment. Any other One Year Production Instances are subject to such additional agreements and fees as the parties agree upon in writing. 

• When the license for a One Year Production Instance expires or is terminated (unless the parties mutually extend the license for a One
Year Production Instance by a further written amendment): (a) Client will immediately discontinue using and accessing the One Year Production Instance; and (b) within the following ten (10) days, Client will certify to Relativity in
writing that Client has completely and permanently uninstalled and permanently discontinued using and accessing the One Year Production Instance, has not made any copies of the Software used therein, and has permanently destroyed the Software used
therein so it cannot be reinstalled or re-used. 
 Temporary Instances 

• A “Temporary Production Instance” is a Production Instance of the Software, and related deployments of the Web
Client Software, that may be deployed on a calendar month-to-month basis. The License under this Agreement permits Client to deploy and use the number of Temporary
Production Instances set forth in Exhibit A.  
 • If Exhibit A permits Client to deploy one or more Temporary
Production Instance(s), Client will pay the Temporary Production Instance Monthly Fee set forth in Exhibit A, plus the Temporary Production Instance Name User Fee set forth in Exhibit A for each Named User who is enabled
to use the Temporary Production Instance in any given month. Notwithstanding anything to the contrary herein, Relativity will not be required to de-duplicate Named Users for any Temporary Production Instance
who are also Named Users in any other Production Instance.  
 • The license for the Temporary Production Instance(s) will
remain in effect on a calendar month-to-month basis until the earlier to occur of: (a) termination of this Agreement; (b) the last day of any calendar month in
which Client delivers notice to Relativity (no later than the last day of such month) electing to terminate the license for the Temporary Production Instance on such last day and certifying that Client has permanently
de-installed, destroyed and discontinued the Temporary Production Instance as further described below; or (c) the last day (“Final Expiration Date”) of the sixth (6th) full
calendar month following the date the license key is issued to Client, subject to the below terms. 
 • During the sixth (6th) full
calendar month: (a) Client’s system administrators who log into the Temporary Production Instance will see an alert advising that a new license key is required to keep using the Temporary Production Instance; (b) if Client does not
request and apply the new license key, the license for the Temporary Production Instance will terminate on the Final Expiration Date described above; (c) if Client requests and applies the new license key, the license for the Temporary
Production Instance will be extended on a month-to-month basis for up to an additional six (6) full calendar months, subject to any earlier termination as described
above, and subject to any further extensions for successive six (6) month periods. 
 • When the license for a Temporary
Production Instance, or any extension thereof, ends or is terminated: (a) the license for the Temporary Production Instance shall expire and Client shall immediately discontinue using and accessing the Temporary Production Instance; and
(b) within the following ten (10) days, Client shall certify to Relativity in writing that Client has completely and permanently uninstalled and permanently discontinued using and accessing the Temporary Production Instance, has not made
any copies of the Software used therein, and has permanently destroyed the Software used therein so it cannot be reinstalled or re-used. 

  
 25 

 • Client may add one or more additional Temporary Production Instances, by paying
Relativity’s applicable fees and signing Relativity’s standard amendment. Any other Temporary Production Instances are subject to such additional agreements and fees as the parties agree upon in writing. 

Free Test and Back-Up Instances 

• General Parameters. Each licensed Production Instance automatically includes a license to deploy and use on the same Client
Computer Network: (a) one (1) related instance of the Software for testing purposes only (“Test Instance”), and (b) one (1) related instance of the Software for back-up and
disaster recovery purposes only (“DR Instance”). In addition, upon Client’s written request, Relativity will provide Client with a license key for one (1) additional Test Instance dedicated to testing any additional
Relativity product that Client is then licensing on a fee-paying basis under this Agreement or any amendment hereto. Each Test Instance is subject to the additional restrictions contained herein: (a) no
more than ten (10) Named Users may be enabled to access each Test Instance in any given calendar month, unless Relativity grants written consent to a higher number for such month; (b) Test Instance(s) shall only be used to test patch
releases and / or other new releases of the applicable Software, and shall not be used for training purposes or to demonstrate the Software to customers or prospects; and (c) for the avoidance of doubt, no Test Instance may contain any data
from any active case or investigation or be used for any production or other purposes respecting any active case or investigation whatsoever. Additional Test Instance restrictions may apply in the license sections respecting specific products, e.g.
respecting the number of Processing Workers in a Test Instance. 
 • Processing Test Instance Restrictions. As described above,
Relativity may provide Client with a license key for one (1) additional Test Instance dedicated to testing Relativity Processing. In such case, Client may deploy one (1) Processing Worker in such additional Processing Test Instance for
every four (4) Processing Workers that Client is licensed to deploy in Production Instances under this Agreement. For example, if Client has licensed between (1) and four (4) Processing Workers to deploy within Production Instances,
Client will receive a license to deploy one (1) Processing Worker within the Processing Test Instance. As another example, if Client has licensed between five (5) and eight (8) Processing Workers to deploy within Production Instances,
Client will receive a license to deploy two (2) Processing Workers within Client’s Processing Test Instance. 
 • Related Provisions.
If Client complies with the restrictions respecting Test Instances and DR Instances, Client will not be required to pay additional fees for deploying or using such Test Instances and DR Instances, and the Named Users of such Test Instances and DR
Instances will not be counted under this Agreement for purposes of determining Extra User Fees. Within a reasonable time after Relativity requests periodically, Client shall cause a knowledgeable officer or manager to review, fill out, and sign
reasonable self-certifications respecting Client’s usage of the Software in the Test Instances and DR Instances that are relevant to determining compliance with the Agreement. Client shall also cooperate in providing Relativity and its
representatives with information and monitored remote access to the Software in the Test Instances and DR Instances to review or audit compliance with the Agreement. Upon Relativity’s request, Client will provide billing and usage data reports
generated through the Relativity Software in the Test Instances and DR Instances. The license to deploy and use Test Instances and DR Instances in this Section is subject to all terms and conditions applicable to the Software contained in the
Agreement, except as provided to the contrary in this Section. 
 RELATIVITY CLIENT DOMAINS 

Relativity Client Domains - Functions Overview. 

• Relativity Client Domains provides a method for Client to enable its customers to access and use certain administrative functions of the
Software, e.g. to enable and disable users, groups, and workspaces within their accounts, without needing to go through Client. 
 •
Client may create Client Domain accounts (each a “Tenant Account”) in any of Client’s licensed Production Instance of the Software, excluding any One Year Production Instances and any Temporary Production Instances. 

  
 26 

 Relativity Client Domains - Licensing and Fees 

• If Exhibit A includes one (1) or more Client Domains, Client will pay the Client Domain Annual Fee for the designated Client
Domain tenants (each a “Tenant”) in Exhibit A. The license and payment requirements for any Client Domain Tenant Accounts will remain in effect through the Term of this Agreement. 

• The Client Domain Annual Fee is due and payable each year in advance on the same date when the Relativity Review Annual Fee is due.

 • If Client begins a Client Domain Tenant Account on any day that is not the same date when the Relativity Review Annual Fee is due,
Client will pay a prorated amount of the Client Domain Annual Fee for a partial annual period to make the Client Domain Tenant Account run to the date when the Relativity Review Annual Fee is due. 

Relativity Client Domains - Other Provisions 

• If Client deletes the Client Domain Tenant Account for a designated tenant (“Prior Client Domain Tenant”),
Client may create a new Client Domain Tenant Account for another Qualified Party as a replacement Client Domain Tenant (“Replacement Client Domain Tenant”), without incurring duplicative Client Domain Annual Fees, as provided below.
However, Client must continue to pay the Client Domain Annual Fees as set forth in Exhibit A, regardless of whether Client procures another Qualified Party as a Replacement Client Domain Tenant. 

• To be a “Qualified Party,” the Replacement Client Domain Tenant must be a bona fide licensed practicing law
firm, corporate law department, or government entity or agency (and must in no event be another litigation support vendor or e-discovery service provider). To create a Replacement Client Domain Tenant Account,
Client may send a “Replacement Activation Request Key” to support@relativity.com which: (i) refers to this Agreement; (ii) identifies the Prior Client Domain Tenant, the full legal name of the Replacement Client
Domain Tenant, and such party’s website; (iii) certifies that Client has deleted the Client Domain Tenant Account for the Prior Client Domain Tenant and that the Replacement Client Domain Tenant is a Qualified Party, and (iv) explains
that Client desires a new Client Domain Activation Key to replace the Prior Client Domain Tenant with the Replacement Client Domain Tenant. 

• Promptly after Relativity receives such a Replacement Activation Request Key and confirms that the Replacement Client Domain Tenant is
a Qualified Party as described above, Relativity will provide Client with an “Activation Key” to enable the Client Domain for the Replacement Client Domain Tenant. If Client subsequently deletes the Client Domain Tenant
Account for the Replacement Client Domain Tenant, Client may then seek to substitute a subsequent Replacement Client Domain Tenant in the same manner as provided herein. 

• By following the above process for Replacement Client Domain Tenants, Client may continue to pay the single annual Client Domain Annual
Fee under this Agreement (rather than incurring duplicative Client Domain Annual Fees respecting each sequential Client Domain Replacement Tenant). For clarity, however, any delay in procuring a Client Domain Replacement Tenant will not excuse
Client from paying Client Domain Annual Fees under this Agreement on a timely basis.     
 • If Client desires to
add more Client Domain Licenses with respect to one or more additional Client Domain Tenants (rather than as Replacement Client Domain Tenants), the parties shall enter into additional amendments identifying the Client Domain Tenants and requiring
additional Client Domain Annual Fees. 
 RELATIVITY PLATFORM: APPLICATION PROGRAMMING INTERFACES. 

Products: Relativity’s Application Programming Interfaces and Relativity Application Framework (collectively, the “APIs”), related
documentation, and any code samples and other materials and information, that Relativity makes available to Client for the purposes herein, all as modified or superseded by Relativity from time to time (collectively, the “Package”).
 

  
 27 

 License: The Relativity product licensed under this Section is the Package described above. There are
no royalties or other fees for the license under this Section. The Package may only be used in conjunction with Client’s licensed use of the Relativity Software under this Agreement and is subject to the other terms herein.  

Purpose 
 • The license granted
herein only permits Client to use the Package for the purposes of: (a) customizing Client’s deployment of the Relativity Software and seeking to provide functional interoperability between the Relativity Software and other products
developed by Client or Client’s vendors Relativity Software (“Other Products”); and (b) creating objects, extensions, applications, and other custom features and functions (“Custom Features”) which
enhance, modify, or add to, existing features and functionality in the Relativity Software. Other Products are subject to the following restrictions: (i) the Other Products must be high quality, well-tested products which enhance the Relativity
Software user experience by adding new or alternative complementary functionality as software plug-ins; (ii) such interoperability shall be limited to importing and/or exporting data between such Other
Products and the Relativity Software; (iii) the Other Products must be developed outside of the Relativity Software and without using the Package or any components thereof, or other components of the Relativity Software provided by Relativity
from time to time under this Agreement, except to the extent required in order to create, and test, functional interoperability between the Other Products and the Relativity Software; and (iv) Client shall comply with all restrictions and other
provisions herein. 
 • If Relativity provides administrative or other assistance to Client respecting Custom Features or Other
Products, such assistance shall not be interpreted as a certification or guaranty that such Custom Features or Other Products will be free of defects or other problems, and Relativity shall have no liability for such defects or other problems. 

Certain Restrictions and Terms 
 •
Client shall comply with all guidelines, requirements, restrictions, and other provisions in the Package, including Relativity’s Documentation respecting the APIs. This Section does not give any rights other than those specifically granted
herein, and specifically does not grant Client or any other party any rights to: (i) execute any software interface definition language (IDL) compiler; (ii) develop and link programs with the Package or Relativity Software libraries
independently of the libraries or classes of the Other Products and Custom Features; (iii) read and use any header files independently of interfaces and/or header files of the Other Products or Custom Features; (iv) copy, incorporate or
embed the Package or any information contained therein, the Relativity Software, or any portion or feature thereof, in any Other Product or Feature; (v) enable the Package, the Relativity Software, or any portion or feature thereof, to be
launched or linked from any Other Product or Features; or (vi) view, copy or use any third parties’ APIs or other software which is included in the Relativity Software or the Package. 

• Relativity’s design documentation, source code for the Relativity Software, and any other source code included with the Package
(other than included header files and sample code in the Package) are confidential and proprietary information and trade secrets of Relativity and its vendors and are under no circumstances licensed to Client. Relativity may enhance, update or
otherwise modify, and replace or otherwise supersede, the Package and/or the Relativity Software or any portion, and may make such items available to Relativity’s customers and/or Client from time to time in Relativity’s discretion.
Relativity does not guaranty or warrant that compatibility will occur and shall have no liability for any lack of backward compatibility. Client shall test for continuing compatibility and shall resolve any resulting compatibility issues. Relativity
may require that Client obtain and use the most recent corrections, updates or releases of the Relativity Software and/or the Package or components for Client to seek functionality and interoperability of the Relativity Software and/or the Package
with Other Products and Custom Features or to minimize requests for Maintenance Support Services, as further described in Exhibit C. 

  
 28 

 Proprietary Rights Clarifications. 

• Other Products. Client (or its vendors as applicable) shall own the entire title and interest in and to all intellectual property
and other proprietary rights related to the Other Products, to the extent that the Other Products do not contain or reference any portion of the Relativity Software or the Package, and all modifications, enhancements, updates, and derivative works
thereof created by Client (or its vendors as applicable), including all copyrights, trademarks, trade secrets and patents appurtenant thereto, and shall have a non-exclusive license to use and exploit any
feedback, suggestions, ideas, enhancement requests, recommendations or other information provided by Relativity relating to the Other Products or any portion thereof. 

• Customer Features. For purposes of this Agreement, all Custom Features shall be deemed Derivative Works of Relativity’s
Relativity Software, and in any event all IP thereto is hereby assigned and shall belong to Relativity; however: (a) Relativity grants Client a non-exclusive, royalty-free, license to use
Client’s Custom Features as provided herein; and (b) Client has no obligation to disclose or provide Client’s Custom Features to Relativity. For the avoidance of doubt, to the extent that Client writes any scripts or source code
outside of and independent of the Package or the Relativity Software, Client shall own such scripts or source code. Client may apply to Relativity for special recognition on Relativity’s web-site based on
Client’s Custom Features from time to time, subject to Relativity’s sole discretion. 
 • Package and Relativity
Software. Relativity (or its vendors as applicable) shall own and shall continue to own the entire title and interest in and to all intellectual property and other proprietary rights related to the Package and the other Relativity Software under
this Agreement, including all enhancements, updates and other modifications, and new releases and Derivative Works thereof, and including all copyrights, trademarks, trade secrets and patents appurtenant thereto, and shall have a non-exclusive license to use and exploit any feedback, suggestions, ideas, enhancement requests, recommendations or other information provided by Client relating to the Package or any portion thereof. For the
avoidance of doubt, to the extent that Client writes any scripts or source code that modify the Package or the Relativity Software, such scripts or source code shall be deemed Derivative Works of Relativity’s Relativity Software, and Relativity
will own such Derivative Works of Relativity’s Relativity Software (while Client will have a non-exclusive license to use them subject to the applicable terms of the Agreement). 

Certain Risks. The Package is optional and not required in order to use the Relativity Software for the basic purposes for which the Relativity
Software was designed. Instead, Relativity makes the Package available as an optional, free, extra tool set. Accordingly, Client’s decision to use the Package shall be at Client’s sole risk, without any representations, warranties or
agreements of any kind by Relativity or any other party whatsoever. Relativity does not warrant that the Package, or any interoperability or integration with Other Products and Custom Features, or their respective functions or results of use, will
be as expected, or be accurate or reliable, or be suitable for Client’s or its customers’ intended uses, or that the operation thereof will be timely, uninterrupted, secure or error-free, or that known or discovered errors will be able to
be corrected or circumvented. 
 Other Terms. Relativity is licensing the Package to Client as permitted above, without any additional fee or charge,
and without any obligation to provide Updates, support or other Services. Relativity may at its option provide Updates, support or other Services without charge or for such charges as Relativity determines. In any event, all restrictions on
Client’s actions respecting the Relativity Software and all disclaimers and limitations respecting representations, warranties and liability of Relativity under this Agreement, shall apply to the Package and any updates, support or other
Services Relativity provides (cumulatively and in addition to the disclaimers and limitations respecting representations, warranties and liability of Relativity under this Section). 

RELATIVITY FACT MANAGER 
 Relativity Fact Manager
assists in organizing and analyzing case details such as facts, issues, organizations, people, interview questions, and documents. This analysis helps identify strengths and weaknesses in litigation strategy, and leads to better preparation for
depositions, interviews, and trial. If Relativity makes Relativity Fact Manager available to Client without additional fees, Relativity nevertheless reserves the right to notify Client that additional fees will be required for future use of the
product. 

  
 29 

 OTHER RELATIVITY PRODUCTS 

Relativity may include with the Software, or otherwise make available, other software products to use with the Software, either without additional fees or as Add-Ons for additional fees. All such products are subject to the terms of this Agreement respecting Relativity Review, except to the extent provided to the contrary in the license documentation or product
Documentation for such products. 
 SPECIAL SERVICES 

• Custom Development. Relativity may provide custom development services. If Client desires such services, Client will pay
Relativity’s then applicable standard fees. Each project requires that the parties enter into a mutually acceptable scope of work agreement with applicable terms and fees. 

• Non-Standard Maintenance and Support. Relativity may provide maintenance, support,
training, set-up, installation or other services that Client requests beyond the standard support services under Exhibit C. If Relativity provides such services, Client will pay Relativity’s then
applicable standard fees. 
 • Solutions Team and Technology Assisted Review. Relativity may provide the services of the
Relativity Solutions Team of Relativity Software administrative professionals to provide commonly requested advice for using certain advanced features of the Software, upon requests by clients, subject to availability, either without charge or for
Relativity’s then applicable standard fees. These services may include training on Relativity Assisted Review (RAR), which is a computer-learning “predictive coding” solution, and related technology assisted functions, such as email
threading and de-duping, conceptual search and clustering. RAR can be used either (1) in a statistically supported manner through a series of random sample set rounds as described in the relevant
Documentation and white papers until human “overturns” of machine coded documents have been reduced to an acceptable confidence level, or (2) by having a “subject matter
expert” “SME” or “Guru” develop a non-random seed set of responsive
documents to train the system to find other responsive documents, and then apply some quality control checks of the results. THE SECOND APPROACH MAY ENHANCE EFFICIENCY, BUT MAY RELY MORE ON JUDGMENTS OF THE SUBJECT MATTER EXPERT THAN
STATISTICALLY SUPPORTED RESULTS. THE RELATIVITY SOLUTIONS TEAM CAN HELP PROVIDE SUGGESTIONS, BUT THE CLIENT SHOULD NEVER VIEW THE RELATIVITY SOLUTIONS TEAM AS AN ACTUAL SME OR GURU IN ANY GIVEN CASE. Relativity Solutions Team is not
qualified, licensed or authorized to provide legal services or to interpret or provide guidance on discovery orders. Rather, Client, its counsel, and its choice of outside litigation support services vendor, are solely responsible for deciding
whether and how to use Relativity Analytics and RAR, and should always consider using the random sample statistically valid approach. UNDER NO CIRCUMSTANCES WILL RELATIVITY HAVE ANY LIABILITY FOR ANY DAMAGES ARISING FROM ANY DECISION TO USE THE SME
/ GURU APPROACH RATHER THAN THE RANDOM SAMPLE STATISTICALLY SUPPORTED APPROACH, EVEN IF THE RELATIVITY SOLUTIONS TEAM PROVIDED ASSISTANCE WITH THE SME / GURU APPROACH. Relativity reserves the right to modify or discontinue the Relativity
Solutions Team service or applicable fees. Relativity will notify Client when Client requests to the Solutions Team or to Relativity involve fee based professional consulting or custom development services. 

  
 30 

 EXHIBIT C 

SOFTWARE MAINTENANCE AND SUPPORT 

Client’s Initial Designated Application Support Administrators: 
  

							
	 	  	 User Name
	  	 Telephone Number
	  	 Email Address

	 1
	  		  		  	
	 2
	  		  		  	
	 3
	  		  		  	

 1. Free Maintenance Support Services. There are no additional fees for the services that are included
under this Exhibit (“Maintenance Support Services”) unless the parties expressly agree otherwise in writing.  

2. Applying Updates Promptly. In order for Client to obtain the benefit of Corrections and enhancements on a timely basis, Client agrees
to apply any Updates to Client’s supported Software within a reasonable time after they become available and Client has had a reasonable time to test them. 

3. Maintenance Support Services Overview. Relativity provides Client’s Designated Application Support Administrators with the
following Maintenance Support Services in accordance with this Agreement: 
  

	 	•	 	 “Standard Technical Support” as further described below 

 

	 	•	 	 “Product Updates and Releases” as further described and limited below 

 

	 	•	 	 Applicable Product Release Notes, product announcements and company information 

 

	 	•	 	 Electronic-based Documentation for Client to install and use the Software 

4. Client’s Designated Application Support Administrators. The Agreement allows Client to designate up to five (5) Designated
Application Support Administrators as points of contact for maintenance and support; the initial contacts are set forth above. Client may update the contacts as needed by sending an email to support@relativity.com. Client must use reasonable
efforts to (a) escalate support issues within Client’s Designated Application Support Administrators, and (b) minimize uncoordinated support requests by different Designated Application Support Administrators regarding the same issue.
Client may also add additional Designated Application Support Administrators, provided: 
 a. All additional Designated
Application Support Administrators shall first successfully participate in Relativity’s applicable two (2) day Relativity Administrative training program (https://relativity.com/ediscovery-training/); 

b. If Client exceeds ten (10) Designated Application Support Administrators, Client shall always include and maintain at least one
(1) full time employee who is a Relativity Certified Administrator (“RCA”), i.e. the person must have successfully passed Relativity’s applicable Relativity Certified Administrator exam, each time Client begins the new
level of ten (10) additional Designated Application Support Administrators (beginning when the first such Designated Application Support Administrator is added within such level). 

c. For example, if Client has eleven (11) to twenty (20) Designated Application Support Administrators, at least one (1) must
be a full time employee who is an RCA. As another example, if Client has twenty-one (21) to thirty (30) Designated Application Support Administrators, at least two (2) must be full time
employees who are RCAs. 
 5. End User Calls and Emails. Client will route all end-user
calls and emails seeking support or maintenance through Client’s Designated Application Support Administrators to Relativity’s Support team for resolution.  

  
 31 

 6. Contacting Relativity Support. The telephone number for Relativity Client Support
is 312-676-5099. Alternatively, Client may send an e-mail to support@relativity.com. All maintenance support calls
and emails are entered into Relativity’s Client Support tracking system. The following information is typically logged for all calls received:  
  

							
	•	  	Date/Time Call Received	  	•	  	Contact Phone Number
				
	•	  	Contact Name	  	•	  	Software Application / Program and Version
				
	•	  	Contact Company	  	•	  	Description of Inquiry
				
	•	  	Contact Email Address	  	•	  	Severity

 Client will receive a “Case Number” from the Relativity Client Support Team representative. Client
should reference this number when requesting any update on the status.  
 7. Standard Technical Support. 

a. Support Hours. Relativity provides Standard Technical Support during Relativity’s regular client support business hours
in its global headquarters. Regular client support business hours for direct phone pick-up by Relativity client support personnel will, at a minimum, include Weekdays, 8:00 am to 8:00 pm US Central Time.
Relativity may extend regular business hours for direct phone pick-up to include additional periods, and Relativity currently has extended regular business hours in place 24/7. In any event, before and after
regular client support business, calls for Severity Level 1 and Severity Level 2 will be forwarded to on-call Relativity personnel to handle consistent with this Exhibit C. 

b. Covered Support. Relativity Standard Technical Support covered by this agreement includes: (i) assisting Client in
diagnosing Errors in the Software; and (ii) providing technical services to Client and/or taking other actions to attempt to provide Corrections of diagnosed Errors. For the purposes of this Agreement: (1) “Error” means an
error, defect, or malfunction in the Software or a mistake in the Documentation that prevents one or more material functions of the Software or the end user’s use thereof from functioning in substantial conformance to the Documentation; and (2)
“Correction” means a change or enhancement respecting such functions of the Software or the Documentation that reestablishes or maintains substantial conformity between the Software and the Documentation. 

c. Support Period. Relativity will provide Standard Technical Support for the Term of the Agreement (“Support Period”)
respecting the Software subject to the following provisions. Each time Relativity issues a new Release, Relativity will continue to provide Standard Technical Support for the superseded Release for a period of at least eighteen (18) months
(“Sunset Support Period”) from the date when the superseded Release originally became generally available, except as otherwise provided herein. The word “Release” in this Exhibit means a Major Release or a Minor
Release, whichever is later. Relativity will also provide Standard Technical Support for Minor Updates issued under the latest Release; however, issuing Minor Updates does not start a new Sunset Support Period for those Minor Updates.
If Relativity issues Releases for different Software products (including Add-Ons) on different schedules, then Relativity may apply the term “Release” herein on a product-by-product basis. In such case, Relativity may modify the existing Sunset Support Period and start a new Sunset Support Period beginning with a new Release of such product to maintain compatibility
with Relativity Review and/or align with the Relativity Review Release cycle.  
 8. Severity Levels And Response Times. This
section provides guidelines that the Relativity Support Team uses to assign a severity level to Client’s problem. Relativity will assign Severity Levels to issues as they are received, but reserves the right to reclassify the Severity Level at
its reasonable discretion. 
 a. Severity 1 – Catastrophic. System is not operational and no work can take place in
the production environment. Catastrophic Severity will be assigned when a production failure results in a debilitating impact to business operations. With all Catastrophic issues, an initial response can be expected as provided in
Section 9 and will include the original support requestor, as well as the appropriate account and Client support leads. Client’s technical staff and Relativity will dedicate staff to work on the problem until resolved. Continual status
updates will be provided until the issue has been resolved. 
 b. Severity 2 – Critical. System is operational; at least
one mission critical function or one entire case is not operational. Critical Severity will be assigned when a critical service interruption or degradation is encountered which creates difficulty but not total impairment in business
operations. For Critical Severity issues, an initial response can be expected as provided in Section 9 and will include the original support requestor, as well as the appropriate account and Client support leads. Client’s technical staff
and Relativity will work continually on the problem during normal business hours unless otherwise agreed upon to resolve the issue. Continual status updates will be provided until the issue has been resolved. 

  
 32 

 c. Severity 3 – Serious. System is operational; at least one non-mission critical function is not operational. Serious Severity will be assigned when some functionality is impaired, but overall Client operations continue to function. For Serious Severity issues, an
initial response can be expected as provided in Section 9 and will include the original support requestor. Relativity will address Serious Severity cases during normal business hours. Status updates will be provided daily until the issue has
been resolved. 
 d. Severity 4 – Minor. All functions are operational; nature of request is cosmetic, a
product enhancement, or a general question. Minor Severity will be assigned to all cosmetic defects, enhancement requests regarding the product, or general questions. For Minor Severity issues, an initial response can be expected as provided
in Section 9 and will include the original support requestor. Relativity will address Minor Severity cases during normal business hours. Status updates will be provided when necessary. 

9. Initial Response Times. Relativity will initially respond to issues based on severity level, as defined above, and time of request.
An initial response may be by phone or email. An initial response will contain the defined severity of the request, initial questions to begin troubleshooting or a potential resolution. Relativity will use commercially reasonable efforts to comply
with the Maximum Initial Response Times in the table below. After hours calls should be limited to issues that are Severity 1 and 2.  
  

					
	Severity Level	  	Maximum Initial Response Time	  	Maximum Initial Response Time
	 	  	 (Normal Business Hours)
	  	 (After Hours Support)

	Severity 1	  	1⁄2 Hour	  	1⁄2 Hour if notified of issue by phone.
		  		  	Next business day if by email.
	Severity 2	  	1 Hour	  	2 Hours if notified of issue by phone.
		  		  	Next business day if by email.
	Severity 3	  	4 Hour	  	NA
	Severity 4	  	24 Hours, if response required	  	NA

 10. System Access. Relativity has no independent means to access Client’s deployment of the
Software.  
 11. Escalating Issues. If Client believes the severity level of Client’s problem is insufficient, contact
Relativity Client Support and request that the severity level be upgraded. If Client feels that a Severity 1 problem is not being adequately addressed, the Client should contact Relativity VP of Operations at +1 (312) 493-4292 .  

12. Electronic Based Documentation. Relativity will make electronic documentation available to Client’s Designated Application
Administrators via the Relativity website at https://relativity.com/support/. Call or email the Relativity Support Team if Client’s Designated Application Administrators do not already have the required information to access this element
of the Relativity website.  
 13. Product Updates and Releases. Relativity may issue Minor Updates, Minor Releases, Major
Releases, Critical Patches and Add-Ons, as described herein and otherwise on such schedule as Relativity determines from time to time. As noted above, the word “Release” in this Exhibit
can refer to either a Major Release or a Minor Release, whichever is later. In connection with each Release, Relativity will seek to provide written release highlights that describe or highlight the enhancements or other changes. Relativity may also
provide new user guides and/or technical reference manuals 
 a. Minor Updates / Monthly Updates. ”Minor
Updates” are modified versions of the Software that are issued on a more frequent regular basis than Minor Releases, and include minor enhancements and/or corrections of defects. If Relativity issues Minor Updates on a regular monthly
basis, Relativity may call them “Monthly Updates.” Relativity may limit Minor Updates to modifying the latest Major or Minor Release. A Minor Update can be distinguished by having a third digit or longer string of digits in the
release number (e.g. Version 9.2.2 or 9.3.237.3). 
 b. Minor Releases. “Minor Releases” are scheduled releases of
modified versions of the Software created to correct defects and/or provide improvements in existing architectural and business features. Relativity may limit Minor Releases to modifying the latest Release of the Software. New Minor Releases are
only included as part of the annual fee pricing during the initial three (3) year term of this Agreement (and during any new three (3) year renewal term if the parties enter into a mutually satisfactory formal written amendment for a
renewal term, unless such amendment provides otherwise). A Minor Release can be distinguished by having two digits in the release number (e.g. Version 9.1). 

  
 33 

 c. Major Releases. “Major Releases” are less frequently scheduled
releases of modified versions of the Software that include upgrades, new application functionality, and/or significant technological advancements compared to the last Major Release. Relativity may consider cumulative improvements provided in Minor
Releases since the last Major Release in determining whether the overall upgrades, new application functionalities, and/or significant technological advancements justify designation of a new Major Release. New Major Releases are only included as
part of the annual fee pricing during the initial three (3) year term of this Agreement (and during any new three (3) year renewal term if the parties enter into a mutually satisfactory formal written amendment for a renewal term, unless
such amendment provides otherwise). A Major Release can be distinguished by having one primary digit in the release number (e.g. Version 9.0).  

d. Critical Patches. “Critical Patches” are unscheduled releases of changes to the Software that Relativity will
provide, if necessary, to address security issues or catastrophic or mission critical defects (Severity Level 1 or 2). Each time Relativity issues a new Release, Relativity will continue to provide Critical Patches for the superseded Release
for a period of at least eighteen (18) months from the date when the superseded Release originally became generally available, except as otherwise provided herein. A Critical Patch can be distinguished by having a third digit or longer string
of digits in the release number (e.g. Version 9.2.2 or 9.3.237.3). 
 e. Add-Ons. Relativity
may make available suites or products of separate functionality that Client may license as an “Add-On” option to Client’s existing Software.
Add-ons are not included as a part of the pricing under this Agreement unless they are expressly licensed in the Exhibits. Add-ons can be distinguished by the
addition of a separate product name or a release number that is independent of this Software.  
 14. Excluded Support.
Examples of services not covered by this Agreement (but which may be available for additional fees as described in Exhibit B payable within thirty (30) days after billed) include:  

 

			
	 •  Administrator or end user training

 
 •  Client requested enhancements
and features
  
 •  Software
installation or onsite support
  

•  Environment configuration
  

•  Translations from English to other languages
	  	 •  Environment trouble shooting issues not associated with Relativity’s
Software
  
 •  Trouble shooting
problems with data not formatted per Relativity’s standard load file specifications
  

•  Database/case migration to or from the Software

  
 34EX-10.1

 Exhibit 10.1 

EXECUTION VERSION 

SECURITIES PURCHASE AGREEMENT 

This SECURITIES PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of July 25, 2019 by and among Solid
Biosciences Inc., a Delaware corporation (the “Company”), and the Investors identified on Exhibit A attached hereto (each an “Investor” and collectively the “Investors”). 

RECITALS 
 A. The Company
and the Investors are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded by the provisions of Section 4(a)(2) of the 1933 Act (as defined below), and Rule 506 of Regulation D
(“Regulation D”) as promulgated by the SEC (as defined below) under the 1933 Act; 
 B. The Investors wish to purchase from
the Company, and the Company wishes to sell and issue to the Investors, upon the terms and subject to the conditions stated in this Agreement, (A) shares (the “Shares”) of the Company’s Common Stock, par value $0.001 per
share (the “Common Stock”) and/or (B) pre-funded warrants in the form attached hereto as Exhibit B to purchase Common Stock (each, a
“Pre-Funded Warrant” and collectively, the “Pre-Funded Warrants”); and 

C. Contemporaneously with the sale of the Shares and Pre-Funded Warrants, the parties hereto will
execute and deliver a Registration Rights Agreement, in the form attached hereto as Exhibit C (the “Registration Rights Agreement”), pursuant to which the Company will agree to provide certain registration
rights in respect of the Shares and the Warrant Shares (as defined below) under the 1933 Act and applicable state securities laws. 
 In
consideration of the mutual promises made herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows: 

1. Definitions. For the purposes of this Agreement, the following terms shall have the meanings set forth below: 

“Affiliate” means, with respect to any Person, any other Person which directly or indirectly through one or more
intermediaries Controls, is controlled by, or is under common Control with such Person. 
 “Business Day” means a day,
other than a Saturday or Sunday, on which banks in New York City are open for the general transaction of business. 

“Closing” has the meaning set forth in Section 3.1. 

“Closing Date” has the meaning set forth in Section 3.1. 

“Common Stock” has the meaning set forth in the recitals to this Agreement. 

 “Common Stock Equivalents” means any securities of the Company which would
entitle the holder thereof to acquire at any time Common Stock, including, without limitation, any debt, preferred stock, rights, options, warrants or other instrument that is at any time convertible into or exchangeable for, or otherwise entitles
the holder thereof to receive, Common Stock. 
 “Company Covered Person” means, with respect to the Company as an
“issuer” for purposes of Rule 506 promulgated under the 1933 Act, any Person listed in the first paragraph of Rule 506(d)(1). 

“Intellectual Property” has the meaning set forth in Section 4.14. 

“Company’s Knowledge” means the actual knowledge of the executive officers (as defined in Rule 405 under the 1933
Act) of the Company. 
 “Control” (including the terms “controlling,” “controlled by” or “under
common control with”) means the possession, direct or indirect, of the power to direct or cause the direction of the management and policies of a Person, whether through the ownership of voting securities, by contract or otherwise. 

“Disqualification Event” has the meaning set forth in Section 4.33. 

“EDGAR system” has the meaning set forth in Section 4.9. 

“Effective Date” has the meaning set forth in Section 7.4(b). 

“Environmental Laws” has the meaning set forth in Section 4.15. 

“GAAP” has the meaning set forth in Section 4.17. 

“Investor Questionnaire” has the meaning set forth in Section 5.8. 

“Losses” has the meaning set forth in Section 8.2. 

“Material Adverse Effect” means a material adverse effect on (i) the assets, liabilities, results of operations,
financial condition or business of the Company and its subsidiaries taken as a whole, (ii) the legality or enforceability of any of the Transaction Documents or (iii) the ability of the Company to perform its obligations under the
Transaction Documents, except that for purposes of Section 6.1(i) of this Agreement, in no event shall a change in the market price of the Common Stock alone constitute a “Material Adverse Effect”. 

“Material Contract” means any contract, instrument or other agreement to which the Company is a party or by which it is bound
that has been filed or was required to have been filed as an exhibit to the SEC Filings pursuant to Item 601(b)(4) or Item 601(b)(10) of Regulation S-K. 

“Nasdaq” means the Nasdaq Global Select Market. 

  
 2 

 “Person” means an individual, corporation, partnership, limited liability
company, trust, business trust, association, joint stock company, joint venture, sole proprietorship, unincorporated organization, governmental authority or any other form of entity not specifically listed herein. 

“Placement Agent” means SVB Leerink LLC. 

“Placement Securities” means the Shares and the Pre-Funded Warrants. 

“Pre-Funded Warrants” has the meaning set forth in the recitals to this Agreement.

 “Press Release” has the meaning set forth in Section 9.7. 

“Principal Trading Market” means the Trading Market on which the Common Stock is primarily listed on and quoted for trading,
which, as of the date of this Agreement and the Closing Date, shall be the Nasdaq Global Select Market. 
 “Registration Rights
Agreement” has the meaning set forth in the recitals to this Agreement. 
 “Regulation D” has the meaning set
forth in the recitals to this Agreement. 
 “Regulatory Authorities” has the meaning set forth in Section 4.30. 

“Required Investors” has the meaning set forth in the Registration Rights Agreement. 

“SEC” means the U.S. Securities and Exchange Commission. 

“SEC Filings” has the meaning set forth in Section 4.8. 

“Securities” means the Placement Securities and the Warrant Shares. 

“Shares” has the meaning set forth in the recitals to this Agreement. 

“Short Sales” means all “short sales” as defined in Rule 200 of Regulation SHO under the 1934 Act (but shall not be
deemed to include the location and/or reservation of borrowable shares of Common Stock). 
 “Trading Day” means (i) a
day on which the Common Stock is listed or quoted and traded on its Principal Trading Market (other than the OTC Bulletin Board), or (ii) if the Common Stock is not listed on a Trading Market (other than the OTC Bulletin Board), a day on which
the Common Stock is traded in the over-the-counter market, as reported by the OTC Bulletin Board, or (iii) if the Common Stock is not quoted on any Trading Market,
a day on which the Common Stock is quoted in the over-the-counter market as reported in the “pink sheets” by OTC Markets Group Inc. (or any similar
organization or agency succeeding to its functions of reporting prices); provided, that in the event that the Common Stock is not listed or quoted as set forth in (i), (ii) or (iii) hereof, then Trading Day shall mean a Business Day. 

  
 3 

 “Trading Market” means whichever of the New York Stock Exchange, the NYSE
American, the Nasdaq Global Select Market, the Nasdaq Global Market, the Nasdaq Capital Market or the OTC Bulletin Board on which the Common Stock is listed or quoted for trading on the date in question. 

“Transfer Agent” has the meaning set forth in Section 7.4(a). 

“Transaction Documents” means this Agreement, the Pre-Funded Warrants and the
Registration Rights Agreement. 
 “Warrant Shares” means the shares of Common Stock issuable upon exercise of the Pre-Funded Warrants. 
 “1933 Act” means the Securities Act of 1933, as amended, or any
successor statute, and the rules and regulations promulgated thereunder. 
 “1934 Act” means the Securities Exchange Act of
1934, as amended, or any successor statute, and the rules and regulations promulgated thereunder. 
 2. Purchase and Sale of the
Placement Securities. On the Closing Date, upon the terms and subject to the conditions set forth herein, the Company will issue and sell, and the Investors will purchase, severally and not jointly, (A) the number of Shares set forth
opposite the name of such Investor under the heading “Number of Shares to be Purchased” on Exhibit A attached hereto and (B) Pre-Funded Warrants to purchase the number of Warrant Shares
set forth opposite the name of such Investor under the heading “Number of Warrant Shares Underlying Pre-Funded Warrant Purchased” on Exhibit A attached hereto, if any. The purchase price per
Share shall be $4.65. The purchase price per Pre-Funded Warrant shall be $4.64. The Pre-Funded Warrants shall have an exercise price equal to $0.01 per Warrant Share and
shall be exercisable for one share of Common Stock (subject to adjustment as provided therein). 
 3. Closing. 

3.1. Upon the satisfaction of the conditions set forth in Section 6, the completion of the purchase and sale of the
Placement Securities (the “Closing”) shall occur remotely via exchange of documents and signatures at a time (the “Closing Date”) to be agreed to by the Company and the Investors but (i) in no event earlier
than the second Business Day after the date hereof and (ii) in no event later than the fifth Trading Day after the date hereof, and of which the Investors will be notified in advance by the Placement Agent. 

3.2. On the Closing Date, each Investor shall deliver or cause to be delivered to the Company, via wire transfer of immediately available
funds pursuant to the wire instructions delivered to such Investor by the Company on or prior to the Closing Date, an amount equal to the purchase price to be paid by the Investor for the Placement Securities to be acquired by it as set forth
opposite the name of such Investor under the heading “Aggregate Purchase Price of Placement Securities” on Exhibit A attached hereto. 

  
 4 

 3.3. At or before the Closing, the Company shall deliver or cause to be delivered to each
Investor (A) a number of Shares, registered in the name of the Investor (or its nominee in accordance with its delivery instructions), equal to the number of Shares set forth opposite the name of such Investor under the heading “Number of
Shares to be Purchased” on Exhibit A attached hereto and (B) a Pre-Funded Warrant, registered in the name of the Investor (or its nominee in accordance with its delivery instructions), to
purchase up to the number of Warrant Shares set forth opposite the name of such Investor under the heading “Number of Warrant Shares Underlying Pre-Funded Warrant Purchased” on Exhibit A
attached hereto, if any. The Shares shall be delivered via a book-entry record through the Company’s transfer agent. Unless the Company and an Investor otherwise mutually agree with respect to such Investor’s Shares, at Closing settlement
shall occur on a “delivery versus payment” basis. 
 4. Representations and Warranties of the Company. The Company hereby
represents and warrants to the Investors that, except (a) as described in the Company’s SEC Filings (as defined below) and (b) as set forth on the disclosure schedule delivered herewith (which is arranged in numbered and lettered
sections corresponding to the numbered and lettered sections contained in this Section 4) (the “Disclosure Schedule”), each of which qualify these representations and warranties in their entirety: 

4.1. Organization, Good Standing and Qualification. The Company is a corporation duly organized, validly existing and in good standing
under the laws of the jurisdiction of its incorporation and has all requisite corporate power and authority to carry on its business as now conducted and to own or lease its properties. The Company is duly qualified to do business as a foreign
corporation and is in good standing in each jurisdiction in which the conduct of its business or its ownership or leasing of property makes such qualification or leasing necessary unless the failure to so qualify has not had and would not reasonably
be expected to have a Material Adverse Effect. The Company’s subsidiaries are set forth on Exhibit 21.1 to its most recent Annual Report on Form 10-K, and the Company owns 100% of the outstanding equity
of all such subsidiaries. The Company’s subsidiaries are duly organized, validly existing and in good standing under the laws of their jurisdiction of incorporation and have all requisite power and authority to carry on their business as now
conducted and to own or lease their properties. The Company’s subsidiaries are duly qualified to do business as foreign corporations and are in good standing in each jurisdiction in which the conduct of their business or their ownership or
leasing of property makes such qualification or leasing necessary unless the failure to so qualify has not had and would not reasonably be expected to have a Material Adverse Effect. 

4.2. Authorization. The Company has the requisite corporate power and authority and has taken all requisite corporate action necessary
for, and no further action on the part of the Company, its officers, directors and stockholders is necessary for, (i) the authorization, execution and delivery of the Transaction Documents, (ii) the authorization of the performance of all
obligations of the Company hereunder or thereunder, and (iii) the authorization, issuance (or reservation for issuance) and delivery of the Placement Securities. The Transaction Documents constitute the legal, valid and binding obligations of
the Company, enforceable against the Company in accordance with their terms, subject to bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and similar laws of general applicability, relating to or affecting creditors’
rights generally and to general equitable principles. 

  
 5 

 4.3. Capitalization. The Company is authorized under its Certificate of Incorporation
to issue 300,000,000 shares of Common Stock. The Company’s disclosure of its issued and outstanding capital stock in its most recent SEC Filing containing such disclosure was accurate in all material respects as of the date indicated in such
SEC Filing. All of the issued and outstanding shares of the Company’s capital stock have been duly authorized and validly issued and are fully paid and nonassessable; none of such shares were issued in violation of any preemptive rights; and
such shares were issued in compliance in all material respects with applicable state and federal securities law and any rights of third parties. No Person is entitled to preemptive or similar statutory or contractual rights with respect to the
issuance by the Company of any securities of the Company, including, without limitation, the Placement Securities. Except for stock options approved pursuant to Company stock-based compensation plans described in the SEC Filings, there are no
outstanding warrants, options, convertible securities or other rights, agreements or arrangements of any character under which the Company is or may be obligated to issue any equity securities of any kind, except as contemplated by this Agreement.
There are no voting agreements, buy-sell agreements, option or right of first purchase agreements or other similar agreements among the Company and any of the securityholders of the Company relating to the
securities of the Company held by them. Except as provided in the Registration Rights Agreement, and except as provided in that certain Amended and Restated Registration Rights Agreement, dated as of March 29, 2017, by and among the Company and
certain investors signatory thereto, no Person has the right to require the Company to register any securities of the Company under the 1933 Act, whether on a demand basis or in connection with the registration of securities of the Company for its
own account or for the account of any other Person. 
 The issuance and sale of the Placement Securities hereunder will not obligate the
Company to issue shares of Common Stock or other securities to any other Person (other than the Investors) and will not result in the adjustment of the exercise, conversion, exchange or reset price of any outstanding security. 

The Company does not have outstanding stockholder purchase rights or “poison pill” or any similar arrangement in effect giving any
Person the right to purchase any equity interest in the Company upon the occurrence of certain events. 
 4.4. Valid Issuance. The
Shares have been duly and validly authorized and, when issued and paid for pursuant to this Agreement, will be validly issued, fully paid and nonassessable, and shall be free and clear of all encumbrances and restrictions (other than those created
by the Investors), except for restrictions on transfer set forth in the Transaction Documents or imposed by applicable securities laws. The Warrant Shares have been duly and validly authorized and reserved for issuance and, upon exercise of the Pre-Funded Warrants in accordance with their terms, including the payment of any exercise price therefor, will be validly issued, fully paid and nonassessable and will be free and clear of all encumbrances and
restrictions (other than those created by the Investors), except for restrictions on transfer set forth in the Transaction Documents or imposed by applicable securities laws. 

  
 6 

 4.5. Consents. Subject to the accuracy of the representations and warranties of each
Investor set forth in Section 5 hereof, the execution, delivery and performance by the Company of the Transaction Documents and the offer, issuance and sale of the Placement Securities require no consent of, action by or in respect of, or
filing with, any Person, governmental body, agency, or official other than (a) filings that have been made pursuant to applicable state securities laws, (b) post-sale filings pursuant to applicable state and federal securities laws,
(c) filings pursuant to the rules and regulations of Nasdaq and (d) filing of the registration statement required to be filed by the Registration Rights Agreement, each of which the Company has filed or undertakes to file within the
applicable time. Subject to the accuracy of the representations and warranties of each Investor set forth in Section 5 hereof, the Company has taken all action necessary to exempt (i) the issuance and sale of the Placement Securities and
(ii) the other transactions contemplated by the Transaction Documents from the provisions of any stockholder rights plan or other “poison pill” arrangement, any anti-takeover, business combination or control share law or statute
binding on the Company or to which the Company or any of its assets and properties is subject that is or could reasonably be expected to become applicable to the Investors as a result of the transactions contemplated hereby, including without
limitation, the issuance of the Placement Securities and the ownership, disposition or voting of the Shares or the Warrant Shares by the Investors or the exercise of any right granted to the Investors pursuant to this Agreement or the other
Transaction Documents. 
 4.6. Use of Proceeds. The net proceeds of the sale of the Placement Securities hereunder shall be used by
the Company for working capital and general corporate purposes. 
 4.7. No Material Adverse Change. Since March 31, 2019, except
as identified and described in the SEC Filings filed at least one Trading Day prior to the date hereof, there has not been: 
 (i) any
change in the consolidated assets, liabilities, financial condition or operating results of the Company from that reflected in the financial statements included in the Company’s Quarterly Report on Form
10-Q for the quarter ended March 31, 2019, except for changes in the ordinary course of business which have not had and would not reasonably be expected to have a Material Adverse Effect, individually or
in the aggregate; 
 (ii) any declaration or payment by the Company of any dividend, or any authorization or payment by the Company of any
distribution, on any of the capital stock of the Company, or any redemption or repurchase by the Company of any securities of the Company; 

(iii) any material damage, destruction or loss, whether or not covered by insurance, to any assets or properties of the Company; 

(iv) any waiver, not in the ordinary course of business, by the Company of a material right or of a material debt owed to it; 

(v) any satisfaction or discharge of any lien, claim or encumbrance or payment of any obligation by the Company, except in the ordinary
course of business and which is not material to the assets, properties, financial condition, operating results or business of the Company (as such business is presently conducted); 

  
 7 

 (vi) any change or amendment to the Company’s Certificate of Incorporation or Bylaws,
or material change to any material contract or arrangement by which the Company is bound or to which any of its assets or properties is subject; 

(vii) any material labor difficulties or, to the Company’s Knowledge, labor union organizing activities with respect to employees of the
Company; 
 (viii) any material transaction entered into by the Company other than in the ordinary course of business; 

(ix) the loss of the services of any key employee, or material change in the composition or duties of the senior management of the Company;
or 
 (x) any other event or condition of any character that has had or would reasonably be expected to have a Material Adverse Effect.

 4.8. SEC Filings. The Company has filed all reports, schedules, forms, statements and other documents required to be filed by the
Company under the 1933 Act and the 1934 Act, including pursuant to Section 13(a) or 15(d) thereof, for the one year period preceding the date hereof (or such shorter period as the Company was required by law or regulation to file such material)
(collectively, the “SEC Filings”). At the time of filing thereof, the SEC Filings complied in all material respects with the requirements of the 1933 Act or the 1934 Act, as applicable, and the rules and regulations of the SEC
thereunder. 
 4.9. No Conflict, Breach, Violation or Default. The execution, delivery and performance of the Transaction Documents
by the Company and the issuance and sale of the Placement Securities in accordance with the provisions thereof will not, except (solely in the case of clauses (i)(b) and (ii)) for such violations, conflicts or defaults as would not reasonably be
expected, individually or in the aggregate, to have a Material Adverse Effect, (i) conflict with or result in a breach or violation of (a) any of the terms and provisions of, or constitute a default under, the Company’s Certificate of
Incorporation or the Company’s Bylaws, both as in effect on the date hereof (true and complete copies of which have been made available to the Investors through the Electronic Data Gathering, Analysis, and Retrieval system (the “EDGAR
system”)), or (b) assuming the accuracy of the representations and warranties in Section 5, any applicable statute, rule, regulation or order of any governmental agency or body or any court, domestic or foreign, having
jurisdiction over the Company or its subsidiaries, or any of their assets or properties, or (ii) conflict with, or constitute a default (or an event that with notice or lapse of time or both would become a default) under, result in the creation
of any lien, encumbrance or other adverse claim upon any of the properties or assets of the Company or its subsidiaries or give to others any rights of termination, amendment, acceleration or cancellation (with or without notice, lapse of time or
both) of, any Material Contract. This Section does not relate to matters with respect to tax status, which are the subject of Section 4.10, employee relations and labor matters, which are the subject of Section 4.13, or environmental laws,
which are the subject of Section 4.15. 

  
 8 

 4.10. Tax Matters. The Company and its subsidiaries have timely prepared and filed
all material tax returns required to have been filed by them with all appropriate governmental agencies and timely paid all material taxes shown thereon or otherwise owed by them. There are no material unpaid assessments against the Company
nor, to the Company’s Knowledge, any audits by any federal, state or local taxing authority. All material taxes that the Company is required to withhold or to collect for payment have been duly withheld and collected and paid to the proper
governmental entity or third party when due. There are no tax liens pending or, to the Company’s Knowledge, threatened against the Company or any of its assets or property. With the exception of agreements or other arrangements that
are not primarily related to taxes entered into in the ordinary course of business, there are no outstanding tax sharing agreements or other such arrangements between the Company and any other corporation or entity (other than a subsidiary of the
Company). 
 4.11. Title to Properties. The Company and its subsidiaries have good and marketable title to all real properties and
all other properties and assets owned by them, in each case free from liens, encumbrances and defects, except such as would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect; and the Company and its
subsidiaries hold any leased real or personal property under valid and enforceable leases with no exceptions, except such as would not reasonably be expected, individually or in the aggregate, to have a Material Adverse Effect. 

4.12. Certificates, Authorities and Permits. The Company possesses adequate certificates, authorities or permits issued by appropriate
governmental agencies or bodies necessary to conduct the business now operated by it, except where failure to so possess would not reasonably be expected, individually or in the aggregate, to result in a Material Adverse Effect. The Company has not
received any written notice of proceedings relating to the revocation or modification of any such certificate, authority or permit that would reasonably be expected to have a Material Adverse Effect, individually or in the aggregate, on the Company.

 4.13. Labor Matters. 

(a) The Company is not party to or bound by any collective bargaining agreements or other agreements with labor organizations. To the
Company’s Knowledge, the Company has not violated in any material respect any laws, regulations, orders or contract terms affecting the collective bargaining rights of employees or labor organizations, or any laws, regulations or orders
affecting employment discrimination, equal opportunity employment, or employees’ health, safety, welfare, wages and hours. 
 (b) No
material labor dispute with the employees of the Company, or with the employees of any principal supplier, manufacturer, customer or contractor of the Company, exists or, to the Company’s Knowledge, is threatened or imminent. 

4.14. Intellectual Property. The Company and its subsidiaries own, possess, license or have other rights to use, all patents, patent
applications, trade and service marks, trade and service mark registrations, trade names, copyrights, licenses, inventions, trade secrets, technology, know-how and other intellectual property (collectively,
the “Intellectual Property”) necessary for the conduct of the Company’s business in all material respects as now conducted or as proposed in the SEC Filings to be conducted; and (a) there are no rights of third parties to
any such Intellectual Property, including no liens, security interests or other encumbrances; (b) to 

  
 9 

 
the Company’s Knowledge, there is no material infringement by third parties of any such Intellectual Property; (c) there is no pending or, to the Company’s Knowledge, threatened
action, suit, proceeding or claim by others challenging the Company’s rights in or to any such Intellectual Property; (d) such Intellectual Property that is described in the SEC Filings has not been adjudged by a court of competent
jurisdiction invalid or unenforceable, in whole or in part; (e) there is no pending or, to the Company’s Knowledge, threatened action, suit, proceeding or claim by others challenging the validity or scope of any such Intellectual Property
that is owned or licensed by the Company, including interferences, oppositions, reexaminations or government proceedings; (f) there is no pending or, to the Company’s Knowledge, threatened action, suit, proceeding or claim by others that
the Company infringes, misappropriates, or otherwise violates any patent, trademark, copyright, trade secret or other proprietary rights of others; and (g) to the Company’s Knowledge, each founder and key employee of the Company and each
Company employee involved with the development of Intellectual Property has entered into an invention assignment agreement with the Company. 

4.15. Environmental Matters. The Company is not in violation of any statute, rule, regulation, decision or order of any governmental
agency or body or any court, domestic or foreign, relating to the use, disposal or release of hazardous or toxic substances or relating to the protection or restoration of the environment or human exposure to hazardous or toxic substances
(collectively, “Environmental Laws”), has not released any hazardous substances regulated by Environmental Law onto any real property that it owns or operates and has not received any written notice or claim it is liable for any off-site disposal or contamination pursuant to any Environmental Laws, which violation, release, notice, claim, or liability would reasonably be expected, individually or in the aggregate, to have a Material Adverse
Effect, and to the Company’s Knowledge, there is no pending or threatened investigation that would reasonably be expected to lead to such a claim. 

4.16. Legal Proceedings. There are no legal, governmental or regulatory investigations, actions, suits or proceedings pending to which
the Company or its subsidiaries are or may reasonably be expected to become a party or to which any property of the Company or its subsidiaries are or may reasonably be expected to become the subject that, individually or in the aggregate, would
reasonably be expected to have a Material Adverse Effect. 
 4.17. Financial Statements. The financial statements included in each
SEC Filing comply in all material respects with applicable accounting requirements and the rules and regulations of the SEC with respect thereto as in effect at the time of filing (or to the extent corrected by a subsequent restatement) and present
fairly, in all material respects, the consolidated financial position of the Company as of the dates shown and its consolidated results of operations and cash flows for the periods shown, subject in the case of unaudited financial statements to
normal, immaterial year-end audit adjustments, and such consolidated financial statements have been prepared in conformity with United States generally accepted accounting principles applied on a consistent
basis during the periods involved (“GAAP”) (except as may be disclosed therein or in the notes thereto, and except that the unaudited financial statements may not contain all footnotes required by GAAP, and, in the case of quarterly
financial statements, except as permitted by Form 10-Q under the 1934 Act). Except as set forth in the financial statements of the Company included in the SEC Filings filed prior to the date hereof, the
Company has not incurred any liabilities, contingent or otherwise, except those incurred in the ordinary course of business, consistent (as to amount and nature) with past practices since the date of such financial statements, none of which,
individually or in the aggregate, have had or would reasonably be expected to have a Material Adverse Effect. 

  
 10 

 4.18. Insurance Coverage. The Company maintains in full force and effect insurance
coverage that is customary for comparably situated companies for the business being conducted and properties owned or leased by the Company, and the Company reasonably believes such insurance coverage to be adequate against all liabilities, claims
and risks against which it is customary for comparably situated companies to insure. 
 4.19. Compliance with Nasdaq Continued Listing
Requirements. The Company is in compliance with applicable Nasdaq continued listing requirements. There are no proceedings pending or, to the Company’s Knowledge, threatened against the Company relating to the continued listing of the
Common Stock on Nasdaq and the Company has not received any notice of, nor to the Company’s Knowledge is there any reasonable basis for, the delisting of the Common Stock from Nasdaq. 

4.20. Brokers and Finders. Other than the Placement Agent, no Person will have, as a result of the transactions contemplated by the
Transaction Documents, any valid right, interest or claim against or upon the Company or an Investor for any commission, fee or other compensation pursuant to any agreement, arrangement or understanding entered into by or on behalf of the Company.
No Investor shall have any obligation with respect to any fees, or with respect to any claims made by or on behalf of other Persons for fees, in each case of the type contemplated by this Section 4.20 that may be due in connection with the
transactions contemplated by this Agreement or the Transaction Documents. 
 4.21. No Directed Selling Efforts or General
Solicitation. Neither the Company nor any Person acting on its behalf has conducted any general solicitation or general advertising (as those terms are used in Regulation D) in connection with the offer or sale of any of the Placement
Securities. 
 4.22. No Integrated Offering. Neither the Company nor its subsidiaries nor any Person acting on their behalf has,
directly or indirectly, made any offers or sales of any Company security or solicited any offers to buy any Company security, under circumstances that would adversely affect reliance by the Company on Section 4(a)(2) and Regulation D for the
exemption from registration for the transactions contemplated hereby or would require registration of the Placement Securities under the 1933 Act. 

4.23. Private Placement. Assuming the accuracy of the representations and warranties of the Investors set forth in Section 5, the
offer and sale of the Placement Securities to the Investors as contemplated hereby is exempt from the registration requirements of the 1933 Act. The issuance and sale of the Placement Securities does not contravene the rules and regulations of
Nasdaq. 

  
 11 

 4.24. Questionable Payments. Neither the Company nor its subsidiaries nor, to the
Company’s Knowledge, any of their current or former directors, officers, employees, agents or other Persons acting on behalf of the Company or its subsidiaries, has on behalf of the Company or its subsidiaries in connection with their business:
(a) used any corporate funds for unlawful contributions, gifts, entertainment or other unlawful expenses relating to political activity; (b) made any direct or indirect unlawful payments to any governmental officials or employees from
corporate funds; (c) established or maintained any unlawful or unrecorded fund of corporate monies or other assets which is in violation of law; (d) made any false or fictitious entries on the books and records of the Company; or
(e) made any unlawful bribe, rebate, payoff, influence payment, kickback or other unlawful payment of any nature. 
 4.25.
Transactions with Affiliates. None of the executive officers or directors of the Company and, to the Company’s Knowledge, none of the employees of the Company is presently a party to any transaction with the Company (other than as
holders of stock options, warrants and/or restricted stock, and for services as employees, officers and directors), including any contract, agreement or other arrangement providing for the furnishing of services to or by, providing for rental of
real or personal property to or from, or otherwise requiring payments to or from any officer, director or such employee or, to the Company’s Knowledge, any entity in which any officer, director, or any such employee has a substantial interest
or is an officer, director, trustee or partner. 
 4.26. Internal Controls. The Company has established and maintains disclosure
controls and procedures (as defined in Rules 13a-15 and 15d-15 under the 1934 Act), which are designed to ensure that material information relating to the Company,
including its subsidiaries, is made known to the Company’s principal executive officer and its principal financial officer by others within those entities. Except as set forth on the Disclosure Schedule, since the end of the Company’s most
recent audited fiscal year, there have been no material weaknesses in the Company’s internal control over financial reporting (whether or not remediated) and no change in the Company’s internal control over financial reporting that has
materially affected, or would reasonably be expected to materially affect, the Company’s internal control over financial reporting. Except as set forth on the Disclosure Schedule, the Company is not aware of any change in its internal controls
over financial reporting that has occurred during its most recent fiscal quarter that has materially affected, or would reasonably be expected to materially affect, the Company’s internal control over financial reporting. 

4.27. Disclosures. Neither the Company nor any Person acting on its behalf has provided the Investors or their agents or counsel with
any information that constitutes or would reasonably be expected to constitute material nonpublic information concerning the Company or its subsidiaries, other than (A) with respect to the transactions contemplated hereby, which will be
disclosed in the Press Release (as defined below) and (B) as set forth on the Disclosure Schedule. The SEC Filings do not contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements
contained therein, in light of the circumstances under which they were made, not misleading. The Company understands and confirms that the Investors will rely on the foregoing representations in effecting transactions in securities of the
Company.
 4.28. Required Filings. Except for the transactions contemplated by this Agreement, including the acquisition of the
Placement Securities contemplated hereby, no event or circumstance has occurred or information exists with respect to the Company or its business, properties, operations or financial condition, which, under applicable law, rule or regulation,
requires public disclosure or announcement by the Company but which has not been so publicly announced or disclosed (assuming for this purpose that the SEC Filings are being incorporated by reference into an effective registration statement filed by
the Company under the 1933 Act). 

  
 12 

 4.29. Investment Company. The Company is not required to be registered as, and
immediately following the Closing will not be required to register as, an “investment company” within the meaning of the Investment Company Act of 1940, as amended. 

4.30. Tests and Preclinical and Clinical Trials. (i) The preclinical studies and clinical trials conducted by or, to the
Company’s Knowledge, on behalf of or sponsored by the Company or its subsidiaries, or in which the Company or its subsidiaries have participated, that are described in the SEC Filings, or the results of which are referred to in the SEC Filings,
as applicable, were, and if still pending are, being conducted in all material respects in accordance with standard medical and scientific research standards and procedures for products or product candidates comparable to those being developed by
the Company and all applicable statutes and all applicable rules and regulations of the U.S. Food and Drug Administration and comparable regulatory agencies outside of the United States to which they are subject, including the European Medicines
Agency (collectively, the “Regulatory Authorities”) and Good Clinical Practice and Good Laboratory Practice requirements; (ii) the descriptions in the SEC Filings of the results of such studies and trials are accurate and
complete descriptions in all material respects and fairly present the data derived therefrom; (iii) to the Company’s Knowledge, there are no other studies or trials not described in the SEC Filings, the results of which the Company
believes are inconsistent with or reasonably call into question the results described or referred to in the SEC Filings; (iv) the Company and its subsidiaries have operated at all times and are currently in compliance with all applicable
statutes, rules and regulations of the Regulatory Authorities, except where such non-compliance would not, individually or in the aggregate, have a Material Adverse Effect; and (v) neither the Company nor
any of its subsidiaries have received any written notices, correspondence or other communications from the Regulatory Authorities or any other governmental agency requiring or threatening the termination, material modification or suspension of any
preclinical studies or clinical trials that are described in the SEC Filings or the results of which are referred to in the SEC Filings, other than ordinary course communications with respect to modifications in connection with the design and
implementation of such studies or trials, and, to the Company’s Knowledge, there are no reasonable grounds for the same. 
 4.31.
Manipulation of Price. The Company has not taken, and, to the Company’s Knowledge, no Person acting on its behalf has taken, directly or indirectly, any action designed to cause or to result in the stabilization or manipulation of
the price of any security of the Company to facilitate the sale or resale of any of the Securities. 
 4.32. Anti-Bribery and Anti-Money
Laundering Laws. Each of the Company, its subsidiaries and any of their respective officers, directors, supervisors, managers, agents, or employees are and have at all times been in compliance with and its participation in the offering will not
violate: (A) anti-bribery laws, including but not limited to, any applicable law, rule, or regulation of any locality, including but not limited to any law, rule, or regulation promulgated to implement the OECD Convention on Combating Bribery
of Foreign Public Officials in International Business Transactions, signed December 17, 1997, including the U.S. Foreign Corrupt Practices Act of 1977, as amended, the U.K. Bribery Act 2010, or any other law, rule or

  
 13 

 
regulation of similar purposes and scope or (B) anti-money laundering laws, including, but not limited to, applicable federal, state, international, foreign or other laws, regulations or
government guidance regarding anti-money laundering, including, without limitation, Title 18 US. Code sections 1956 and 1957, the Patriot Act, the Bank Secrecy Act, and international anti-money laundering principles or procedures by an
intergovernmental group or organization, such as the Financial Action Task Force on Money Laundering, of which the United States is a member and with which designation the United States representative to the group or organization continues to
concur, all as amended, and any Executive order, directive, or regulation pursuant to the authority of any of the foregoing, or any orders or licenses issued thereunder. 

4.33. No Bad Actors. No “bad actor” disqualifying event described in Rule 506(d)(1)(i)-(viii) of the 1933 Act (a
“Disqualification Event”) is applicable to the Company or, to the Company’s Knowledge, any Company Covered Person, except (i) for a Disqualification Event as to which Rule 506(d)(2)(ii–iv) or (d)(3) is applicable and
(ii) no such representation is made with respect to the Placement Agent, or any of their respective general partners, managing members, directors, executive officers or other officers. 

4.34. No Additional Agreements. The Company has no other agreements or understandings (including, without limitation, side letters)
with any Investor to purchase Placement Securities on terms more favorable to such Investor than as set forth herein. 
 4.35. Shell
Company Status. The Company is not, and has never been, an issuer identified in Rule 144(i)(1). 
 5. Representations and Warranties
of the Investors. Each of the Investors hereby severally, and not jointly, represents and warrants to the Company that: 
 5.1.
Organization and Existence. Such Investor is a duly incorporated or organized and validly existing corporation, limited partnership, limited liability company or other legal entity, has all requisite corporate, partnership or limited
liability company power and authority to enter into and consummate the transactions contemplated by the Transaction Documents and to carry out its obligations hereunder and thereunder, and to invest in the Securities pursuant to this Agreement, and
is in good standing under the laws of the jurisdiction of its incorporation or organization. 
 5.2. Authorization. The execution,
delivery and performance by such Investor of the Transaction Documents to which such Investor is a party have been duly authorized and each has been duly executed and when delivered will constitute the valid and legally binding obligation of such
Investor, enforceable against such Investor in accordance with their respective terms, subject to bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and similar laws of general applicability, relating to or affecting
creditors’ rights generally, and general principles of equity. 

  
 14 

 5.3. Purchase Entirely for Own Account. The Securities to be received by such
Investor hereunder will be acquired for such Investor’s own account, not as nominee or agent, for the purpose of investment and not with a view to the resale or distribution of any part thereof in violation of the 1933 Act, and such Investor
has no present intention of selling, granting any participation in, or otherwise distributing the same in violation of the 1933 Act without prejudice, however, to such Investor’s right at all times to sell or otherwise dispose of all or any
part of such Securities in compliance with applicable federal and state securities laws. The Placement Securities are being purchased by such Investor in the ordinary course of its business. Nothing contained herein shall be deemed a representation
or warranty by such Investor to hold the Securities for any period of time. Such Investor is not a broker-dealer registered with the SEC under the 1934 Act or an entity engaged in a business that would require it to be so registered. 

5.4. Investment Experience. Such Investor acknowledges that it can bear the economic risk and complete loss of its investment in the
Securities and has such knowledge and experience in financial or business matters that it is capable of evaluating the merits and risks of the investment contemplated hereby. 

5.5. Disclosure of Information. Such Investor has had an opportunity to receive, review and understand all information related to the
Company requested by it and to ask questions of and receive answers from the Company regarding the Company, its business and the terms and conditions of the offering of the Securities, and has conducted and completed its own independent due
diligence. Such Investor acknowledges that copies of the SEC Filings are available on the EDGAR system. Based on the information such Investor has deemed appropriate, and without reliance upon the Placement Agent, it has independently made its own
analysis and decision to enter into the Transaction Documents. Such Investor is relying exclusively on its own investment analysis and due diligence (including professional advice it deems appropriate) with respect to the execution, delivery and
performance of the Transaction Documents, the Securities and the business, condition (financial and otherwise), management, operations, properties and prospects of the Company, including but not limited to all business, legal, regulatory,
accounting, credit and tax matters. Such Investor has not relied on any information or advice furnished by or on behalf of the Placement Agent in connection with the transactions contemplated hereby. Neither such inquiries nor any other due
diligence investigation conducted by such Investor shall modify, limit or otherwise affect such Investor’s right to rely on the Company’s representations and warranties contained in this Agreement. 

5.6. Restricted Securities. Such Investor understands that the Securities are characterized as “restricted securities” under
the U.S. federal securities laws inasmuch as they are being acquired from the Company in a transaction not involving a public offering and that under such laws and applicable regulations such securities may be resold without registration under the
1933 Act only in certain limited circumstances. 
 5.7. Legends. It is understood that, except as provided below, certificates
evidencing the Securities may bear the following or any similar legend: 
 (a) “These securities represented hereby [and the securities
issuable upon exercise of these securities] have not been registered with the Securities and Exchange Commission or the securities commission of any state in reliance upon an exemption from registration under the Securities Act of 1933, as amended,
and, accordingly, may not be transferred unless (i) such securities have been registered for sale pursuant to the Securities Act of 1933, as amended, (ii) such securities may be sold pursuant to Rule 144, (iii) the Company has

  
 15 

 
received an opinion of counsel reasonably satisfactory to it that such transfer may lawfully be made without registration under the Securities Act of 1933, as amended, or (iv) the securities
are transferred without consideration to an affiliate of such holder or a custodial nominee (which for the avoidance of doubt shall require neither consent nor the delivery of an opinion).” 

(b) If required by the authorities of any state in connection with the issuance of sale of the Securities, the legend required by such state
authority. 
 5.8. Accredited Investor. Such Investor is (a) an “accredited investor” within the meaning of Rule
501(a) of Regulation D. Such Investor has executed and delivered to the Company a questionnaire in substantially the form attached hereto as Exhibit D (the “Investor Questionnaire”), which such Investor represents and
warrants is true, correct and complete. Such investor is a sophisticated institutional investor with sufficient knowledge and experience in investing in private equity transactions to properly evaluate the risks and merits of its purchase of the
Securities. Such Investor has determined based on its own independent review and such professional advice as it deems appropriate that its purchase of the Securities and participation in the transactions contemplated by the Transaction Documents
(i) are fully consistent with its financial needs, objectives and condition, (ii) comply and are fully consistent with all investment policies, guidelines and other restrictions applicable to such Investor, (iii) have been duly
authorized and approved by all necessary action, (iv) do not and will not violate or constitute a default under such Investor’s charter, bylaws or other constituent document or under any law, rule, regulation, agreement or other obligation
by which such Investor is bound and (v) are a fit, proper and suitable investment for such Investor, notwithstanding the substantial risks inherent in investing in or holding the Securities. 

5.9. Placement Agent. Such Investor hereby acknowledges and agrees that (a) the Placement Agent is acting solely as placement
agent in connection with the execution, delivery and performance of the Transaction Documents and is not acting as an underwriter or in any other capacity and is not and shall not be construed as a fiduciary for such Investor, the Company or any
other person or entity in connection with the execution, delivery and performance of the Transaction Documents, (b) the Placement Agent has not made and will not make any representation or warranty, whether express or implied, of any kind or
character, and has not provided any advice or recommendation in connection with the execution, delivery and performance of the Transaction Documents, (c) the Placement Agent will not have any responsibility with respect to (i) any
representations, warranties or agreements made by any person or entity under or in connection with the execution, delivery and performance of the Transaction Documents, or the execution, legality, validity or enforceability (with respect to any
person) thereof, or (ii) the business, affairs, financial condition, operations, properties or prospects of, or any other matter concerning the Company, and (d) the Placement Agent will not have any liability or obligation (including
without limitation, for or with respect to any losses, claims, damages, obligations, penalties, judgments, awards, liabilities, costs, expenses or disbursements incurred by such Investor, the Company or any other person or entity), whether in
contract, tort or otherwise, to such Investor, or to any person claiming through it, in respect of the execution, delivery and performance of the Transaction Documents. 

  
 16 

 5.10. No General Solicitation. Such Investor did not learn of the investment in the
Securities as a result of any general or public solicitation or general advertising, or publicly disseminated advertisements or sales literature, including (a) any advertisement, article, notice or other communication published in any
newspaper, magazine, website, or similar media, or broadcast over television or radio, or (b) any seminar or meeting to which such Investor was invited by any of the foregoing means of communications. 

5.11. Brokers and Finders. No Person will have, as a result of the transactions contemplated by the Transaction Documents, any valid
right, interest or claim against or upon the Company or an Investor for any commission, fee or other compensation pursuant to any agreement, arrangement or understanding entered into by or on behalf of such Investor. 

5.12. Short Sales and Confidentiality Prior to the Date Hereof. Other than consummating the transactions contemplated hereunder, such
Investor has not, nor has any Person acting on behalf of or pursuant to any understanding with such Investor, directly or indirectly executed any purchases or sales, including Short Sales, of the securities of the Company during the period
commencing as of the time that such Investor was first contacted by the Company, the Placement Agent or any other Person regarding the transactions contemplated hereby and ending immediately prior to the date hereof. Notwithstanding the
foregoing, in the case of an Investor that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Investor’s assets and the portfolio managers have no direct knowledge of the investment
decisions made by the portfolio managers managing other portions of such Investor’s assets, the representation set forth above shall only apply with respect to the portion of assets managed by the portfolio manager that made the investment
decision to purchase the Securities covered by this Agreement. Other than to other Persons party to this Agreement and other than to such Person’s outside attorney, accountant, auditor or investment advisor only to the extent necessary to
permit evaluation of the investment, and the performance of the necessary or required tax, accounting, financial, legal, or administrative tasks and services and other than as may be required by law, such Investor has maintained the confidentiality
of all disclosures made to it in connection with this transaction (including the existence and terms of this transaction). Notwithstanding the foregoing, for avoidance of doubt, nothing contained herein shall constitute a representation or warranty,
or preclude any actions, with respect to the identification of the availability of, or securing of, available shares to borrow in order to effect Short Sales or similar transactions in the future. 

5.13. No Government Recommendation or Approval. Such Investor understands that no United States federal or state agency, or similar
agency of any other country, has reviewed, approved, passed upon, or made any recommendation or endorsement of the Company or the purchase of the Securities. 

5.14. No Intent to Effect a Change of Control. Such Investor has no present intent to effect a “change of control” of the
Company as such term is understood under the rules promulgated pursuant to Section 13(d) of the 1934 Act. 
 5.15. Residency.
Such Investor’s office in which its investment decision with respect to the Securities was made is located at the address immediately below such Investor’s name on its signature page hereto. 

  
 17 

 5.16. No Conflicts. The execution, delivery and performance by such Investor of the
Transaction Documents and the consummation by such Investor of the transactions contemplated hereby and thereby will not (i) result in a violation of the organizational documents of such Investor or (ii) conflict with, or constitute a
default (or an event which with notice or lapse of time or both would become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation of, any agreement, indenture or instrument to which such Investor is
a party, or (iii) result in a violation of any law, rule, regulation, order, judgment or decree (including federal and state securities laws) applicable to such Investor, except in the case of clauses (ii) and (iii) above, for such
conflicts, defaults, rights or violations which would not, individually or in the aggregate, reasonably be expected to have a material adverse effect on the ability of such Investor to perform its obligations hereunder. 

6. Conditions to Closing. 

6.1. Conditions to the Investors’ Obligations. The obligation of each Investor to purchase Placement Securities at the Closing is
subject to the fulfillment to such Investor’s satisfaction, on or prior to the Closing Date, of the following conditions, any of which may be waived by such Investor (as to itself only): 

(a) The representations and warranties made by the Company in Section 4 hereof shall be true and correct in all material respects as of
the date hereof and as of the Closing Date, as though made on and as of such date, except to the extent any such representation or warranty expressly speaks as of an earlier date, in which case such representation or warranty shall be true and
correct in all material respects as of such earlier date. The Company shall have performed in all material respects all obligations and covenants herein required to be performed by it on or prior to the Closing Date. 

(b) The Company shall have obtained any and all consents, permits, approvals, registrations and waivers necessary for the consummation of the
purchase and sale of the Placement Securities and the consummation of the other transactions contemplated by the Transaction Documents, all of which shall be in full force and effect. 

(c) The Company shall have executed and delivered the Registration Rights Agreement. 

(d) The Company shall have filed with Nasdaq a Notification Form: Listing of Additional Shares for the listing of the Shares and the Warrant
Shares. 
 (e) No judgment, writ, order, injunction, award or decree of or by any court, or judge, justice or magistrate, including any
bankruptcy court or judge, or any order of or by any governmental authority, shall have been issued, and no action or proceeding shall have been instituted by any governmental authority, enjoining or preventing the consummation of the transactions
contemplated hereby or in the other Transaction Documents. 
 (f) The Company shall have delivered a Certificate, executed on behalf of the
Company by its Chief Executive Officer or its Chief Financial Officer, dated as of the Closing Date, certifying to the fulfillment of the conditions specified in subsections (a), (b), (d), (e) and (j) of this Section 6.1. 

  
 18 

 (g) The Company shall have delivered a Certificate, executed on behalf of the Company by its
Secretary, dated as of the Closing Date, certifying the resolutions adopted by the Board of Directors of the Company approving the transactions contemplated by this Agreement, the other Transaction Documents and the issuance of the Placement
Securities, certifying the current versions of the Certificate of Incorporation and Bylaws of the Company and certifying as to the signatures and authority of persons signing the Transaction Documents and related documents on behalf of the Company.

 (h) The Investors shall have received an opinion from Wilmer Cutler Pickering Hale and Dorr LLP, the Company’s counsel, dated as of
the Closing Date, in form and substance reasonably acceptable to the Investors and addressing such legal matters as the Investors may reasonably request. 

(i) There shall have been no Material Adverse Effect with respect to the Company since the date hereof. 

(j) No stop order or suspension of trading shall have been imposed by Nasdaq, the SEC or any other governmental or regulatory body with
respect to public trading in the Common Stock. 
 6.2. Conditions to Obligations of the Company. The Company’s obligation to
sell and issue Placement Securities at the Closing is subject to the fulfillment to the satisfaction of the Company on or prior to the Closing Date of the following conditions, any of which may be waived by the Company: 

(a) The representations and warranties made by the Investors in Section 5 hereof shall be true and correct as of the date hereof, and
shall be true and correct as of the Closing Date with the same force and effect as if they had been made on and as of such date. The Investors shall have performed in all material respects all obligations and covenants herein required to be
performed by them on or prior to the Closing Date. 
 (b) The Investors shall have executed and delivered the Registration Rights Agreement
and each Investor Questionnaire. 
 (c) Any Investor purchasing Placement Securities at the Closing shall have paid in full its purchase
price to the Company. 
 6.3. Termination of Obligations to Effect Closing; Effects. 

(a) The obligations of the Company, on the one hand, and the Investors, on the other hand, to effect the Closing shall terminate as follows:

 (i) Upon the mutual written consent of the Company and Investors that agreed to purchase a majority of the Placement Securities to be
issued and sold pursuant to this Agreement; 
 (ii) By the Company if any of the conditions set forth in Section 6.2 shall have become
incapable of fulfillment, and shall not have been waived by the Company; 

  
 19 

 (iii) By an Investor (with respect to itself only) if any of the conditions set forth in
Section 6.1 shall have become incapable of fulfillment, and shall not have been waived by the Investor; or 
 (iv) By either the
Company or any Investor (with respect to itself only) if the Closing has not occurred on or prior to the fifth Trading Day following the date of this Agreement; 

provided, however, that, except in the case of clause (i) above, the party seeking to terminate its obligation to effect the Closing shall not then be in
breach of any of its representations, warranties, covenants or agreements contained in this Agreement or the other Transaction Documents if such breach has resulted in the circumstances giving rise to such party’s seeking to terminate its
obligation to effect the Closing. 
 (b) In the event of termination by the Company or any Investor of its obligations to effect the Closing
pursuant to this Section 6.3, written notice thereof shall be given to the other Investors by the Company and the other Investors shall have the right to terminate their obligations to effect the Closing upon written notice to the Company and
the other Investors. Nothing in this Section 6.3 shall be deemed to release any party from any liability for any breach by such party of the terms and provisions of this Agreement or the other Transaction Documents or to impair the right of any
party to compel specific performance by any other party of its obligations under this Agreement or the other Transaction Documents. 
 7.
Covenants and Agreements of the Company. 
 7.1. No Conflicting Agreements. The Company will not take any action, enter into
any agreement or make any commitment that would conflict or interfere in any material respect with the Company’s obligations to the Investors under the Transaction Documents. 

7.2. Nasdaq Listing. The Company will use commercially reasonable efforts to continue the listing and trading of its Common Stock on
Nasdaq and, in accordance therewith, will use commercially reasonable efforts to comply in all material respects with the Company’s reporting, filing and other obligations under the bylaws or rules of such market or exchange, as applicable.

 7.3. Termination of Covenants. The provisions of Sections 7.1 and 7.2 shall terminate and be of no further force and effect
on the date on which the Company’s obligations under the Registration Rights Agreement to register or maintain the effectiveness of any registration covering the Registrable Securities (as such term is defined in the Registration Rights
Agreement) shall terminate. 
 7.4. Removal of Legends. 

(a) In connection with any sale, assignment, transfer or other disposition of the Shares or Warrant Shares by an Investor pursuant to
Rule 144 or pursuant to any other exemption under the 1933 Act such that the purchaser acquires freely tradable shares and upon compliance by the Investor with the requirements of this Agreement, if requested by the Investor, the Company shall
request the transfer agent for the Common Stock (the “Transfer Agent”) to 

  
 20 

 
remove any restrictive legends related to the book entry account holding such Shares or Warrant Shares and make a new, unlegended entry for such book entry shares sold or disposed of without
restrictive legends within three (3) Trading Days of any such request therefor from such Investor, provided that the Company has timely received from the Investor customary representations and other documentation reasonably acceptable to the
Company in connection therewith. 
 (b) Subject to receipt from the Investor by the Company and the Transfer Agent of customary
representations and other documentation reasonably acceptable to the Company and the Transfer Agent in connection therewith, upon the earliest of such time as the Shares or Warrant Shares (i) have been sold or transferred pursuant to an
effective registration statement, (ii) have been sold pursuant to Rule 144, or (iii) are eligible for resale under Rule 144(b)(1) or any successor provision (such earliest date, the “Effective Date”), the Company
shall, in accordance with the provisions of this Section 7.4(b) and within three (3) Trading Days of any request therefor from an Investor accompanied by such customary and reasonably acceptable documentation referred to above,
(A) deliver to the Transfer Agent irrevocable instructions that the Transfer Agent shall make a new, unlegended entry for such book entry Shares or Warrant Shares, and (B) cause its counsel to deliver to the Transfer Agent one or more
opinions to the effect that the removal of such legends in such circumstances may be effected under the 1933 Act if required by the Transfer Agent to effect the removal of the legend in accordance with the provisions of this Agreement. Shares or
Warrant Shares subject to legend removal hereunder may be transmitted by the Transfer Agent to the Investor by crediting the account of the Investor’s prime broker with the DTC System as directed by such Investor. The Company shall be
responsible for the fees of its Transfer Agent and all DTC fees associated with such issuance. 
 (c) Each Investor, severally and not
jointly with the other Investors, agrees with the Company (i) that such Investor will sell any Securities only pursuant to either the registration requirements of the 1933 Act, including any applicable prospectus delivery requirements, or an
exemption therefrom, (ii) that if Shares or Warrant Shares are sold pursuant to a registration statement, they will be sold in compliance with the plan of distribution set forth therein and (iii) that if, after the effective date of the
registration statement covering the resale of the Shares and the Warrant Shares, such registration statement ceases to be effective and the Company has provided notice to such Investor to that effect, such Investor will sell Shares and Warrant
Shares only in compliance with an exemption from the registration requirements of the 1933 Act. 
 7.5. Subsequent Equity Sales. 

(a) From the date hereof until forty-five (45) days after the Closing Date, without the consent of the Required Investors, the Company
shall not (A) issue shares of Common Stock or Common Stock Equivalents, (B) effect a reverse stock split, recapitalization, share consolidation, reclassification or similar transaction affecting the outstanding Common Stock or
(C) file with the SEC a registration statement under the 1933 Act relating to any shares of Common Stock or Common Stock Equivalents, except pursuant to the terms of the Registration Rights Agreement and any other agreements to which the
Company is currently a party. Notwithstanding the foregoing, the provisions of this Section 7.5 shall not apply to (i) the issuance of the Securities hereunder, (ii) the issuance of Common Stock or Common Stock

  
 21 

 
Equivalents upon the conversion or exercise of any securities of the Company outstanding on the date hereof or outstanding pursuant to clause (iii) or (v) below, (iii) the issuance of
any Common Stock or Common Stock Equivalents pursuant to any Company stock-based compensation plans or in accordance with Nasdaq Stock Market Rule 5635(c)(4), (iv) the filing of a registration statement on Form
S-8 under the 1933 Act to register the offer and sale of securities on an equity incentive plan or employee stock purchase plan or (v) the issuance of any Common Stock or Common Stock Equivalents in
connection with a transaction with an unaffiliated third party that includes a bona fide commercial relationship with the Company (including any joint venture, marketing or distribution arrangement, strategic alliance, collaboration agreement or
corporate partnering, intellectual property license agreement or acquisition agreement or other strategic transaction or debt financing transaction with the Company); provided, however, that the aggregate number of shares of Common Stock issued
pursuant to clause (v) during the restricted period shall not exceed 10% of the total number of shares of Common Stock issued and outstanding immediately following the Closing. 

(b) The Company shall not, and shall use its commercially reasonable efforts to ensure that no Affiliate of the Company shall, sell, offer for
sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section 2 of the 1933 Act) that will be integrated with the offer or sale of the Placement Securities in a manner that would require the registration
under the 1933 Act of the sale of the Placement Securities to the Investors, or that will be integrated with the offer or sale of the Placement Securities for purposes of the rules and regulations of any trading market such that it would require
stockholder approval prior to the closing of such other transaction unless stockholder approval is obtained before the closing of such subsequent transaction. 

7.6. Fees. The Company shall be responsible for the payment of any placement agent’s fees, financial advisory fees, or
broker’s commissions (other than for Persons engaged by any Investor) relating to or arising out of the transactions contemplated hereby, including, without limitation, any fees or commissions payable to the Placement Agent. 

7.7. Short Sales and Confidentiality After the Date Hereof. Each Investor covenants that neither it nor any Affiliates acting on its
behalf or pursuant to any understanding with it will execute any Short Sales during the period from the date hereof until the earlier of such time as (i) the transactions contemplated by this Agreement are first publicly announced or
(ii) this Agreement is terminated in full. Each Investor covenants that until such time as the transactions contemplated by this Agreement are publicly disclosed by the Company, such Investor will maintain the confidentiality of all disclosures
made to it in connection with this transaction (including the existence and terms of this transaction), other than to such Person’s outside attorney, accountant, auditor or investment advisor only to the extent necessary to permit evaluation of
the investment, and the performance of the necessary or required tax, accounting, financial, legal, or administrative tasks and services and other than as may be required by law. Each Investor understands and acknowledges that the SEC currently
takes the position that coverage of Short Sales of shares of the Common Stock “against the box” prior to effectiveness of a resale registration statement with securities included in such registration statement would be a violation of
Section 5 of the 1933 Act, as set forth in Item 239.10 of the Securities Act Rules Compliance and Disclosure Interpretations compiled by the Office of Chief Counsel, Division of Corporation Finance. 

  
 22 

 8. Survival and Indemnification. 

8.1. Survival. The representations, warranties, covenants and agreements contained in this Agreement shall survive the Closing of the
transactions contemplated by this Agreement for the applicable statute of limitations. 
 8.2. Indemnification. The Company agrees to
indemnify and hold harmless each Investor and its Affiliates, and their respective directors, officers, trustees, members, managers, employees, investment advisers and agents, from and against any and all losses, claims, damages, liabilities and
expenses (including without limitation reasonable and documented attorney fees and disbursements and other documented out-of-pocket expenses reasonably incurred in
connection with investigating, preparing or defending any action, claim or proceeding, pending or threatened and the costs of enforcement thereof) (collectively, “Losses”) to which such Person may become subject as a result of any
breach of representation, warranty, covenant or agreement made by or to be performed on the part of the Company under the Transaction Documents, and will reimburse any such Person for all such amounts as they are incurred by such Person solely to
the extent such amounts have been finally judicially determined not to have resulted from such Person’s fraud or willful misconduct. 

8.3. Conduct of Indemnification Proceedings. Any person entitled to indemnification hereunder shall (i) give prompt
written notice to the indemnifying party of any claim with respect to which it seeks indemnification and (ii) permit such indemnifying party to assume the defense of such claim with counsel reasonably satisfactory to the indemnified party;
provided that any person entitled to indemnification hereunder shall have the right to employ separate counsel and to participate in the defense of such claim, but the fees and expenses of such counsel shall be at the expense of such person
unless (a) the indemnifying party has agreed in writing to pay such fees or expenses, (b) the indemnifying party shall have failed to assume the defense of such claim and employ counsel reasonably satisfactory to such person or (c) in
the reasonable judgment of any such person, based upon written advice of its counsel, a conflict of interest exists between such person and the indemnifying party with respect to such claims (in which case, if the person notifies the indemnifying
party in writing that such person elects to employ separate counsel at the expense of the indemnifying party, the indemnifying party shall not have the right to assume the defense of such claim on behalf of such person); and provided,
further, that the failure of any indemnified party to give written notice as provided herein shall not relieve the indemnifying party of its obligations hereunder, except to the extent that such failure to give notice shall materially
adversely affect the indemnifying party in the defense of any such claim or litigation. It is understood that the indemnifying party shall not, in connection with any proceeding in the same jurisdiction, be liable for fees or expenses of more than
one separate firm of attorneys at any time for all such indemnified parties. No indemnifying party will, except with the consent of the indemnified party, which consent shall not be unreasonably withheld, conditioned or delayed, consent to entry of
any judgment or enter into any settlement that does not include as an unconditional term thereof the giving by the claimant or plaintiff to such indemnified party of a release from all liability in respect of such claim or litigation. No indemnified
party will, except with the consent of the indemnifying party, which consent shall not be unreasonably withheld, conditioned or delayed, consent to entry of any judgment or enter into any settlement. 

  
 23 

 9. Miscellaneous. 

9.1. Successors and Assigns. This Agreement may not be assigned by a party hereto without the prior written consent of the Company or
each of the Investors, as applicable, provided, however, that an Investor may assign its rights and delegate its duties hereunder in whole or in part to an Affiliate or to a third party acquiring some or all of its Securities in a transaction
complying with applicable securities laws without the prior written consent of the Company or the other Investors, provided such assignee agrees in writing to be bound by the provisions hereof that apply to Investors. The provisions of this
Agreement shall inure to the benefit of and be binding upon the respective permitted successors and assigns of the parties. Without limiting the generality of the foregoing, in the event that the Company is a party to a merger, consolidation, share
exchange or similar business combination transaction in which the Common Stock is converted into the equity securities of another Person, from and after the effective time of such transaction, such Person shall, by virtue of such transaction, be
deemed to have assumed the obligations of the Company hereunder, the term “Company” shall be deemed to refer to such Person and the term “Securities” shall be deemed to refer to the securities received by the Investors in
connection with such transaction. Nothing in this Agreement, express or implied, is intended to confer upon any party other than the parties hereto or their respective permitted successors and assigns any rights, remedies, obligations, or
liabilities under or by reason of this Agreement, except as expressly provided in this Agreement. 
 9.2. Counterparts. This
Agreement may be executed in one or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Counterparts may be delivered via facsimile, electronic mail (including pdf or
any electronic signatures complying with the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com) or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for
all purposes. 
 9.3. Titles and Subtitles. The titles and subtitles used in this Agreement are used for convenience only and are not
to be considered in construing or interpreting this Agreement. 
 9.4. Notices. Unless otherwise provided, any notice required or
permitted under this Agreement shall be given in writing and shall be deemed effectively given as hereinafter described (i) if given by personal delivery, then such notice shall be deemed given upon such delivery, (ii) if given by
facsimile or e-mail, then such notice shall be deemed given upon receipt of confirmation of complete facsimile transmittal or confirmation of receipt of an e-mail
transmission, (iii) if given by mail, then such notice shall be deemed given upon the earlier of (A) receipt of such notice by the recipient or (B) three days after such notice is deposited in first class mail, postage prepaid, and
(iv) if given by an internationally recognized overnight air courier, then such notice shall be deemed given one Business Day after delivery to such carrier. All notices shall be addressed to the party to be notified at the address as follows,
or at such other address as such party may designate by ten days’ advance written notice to the other party: 
 If to the Company: 

Solid Biosciences Inc. 
 141
Portland Street, Fifth Floor 
 Cambridge, MA 02139 

Attention: Lynette Herscha, Chief Legal Officer 

Email: lynette@solidbio.com 

  
 24 

 With a copy (which shall not constitute notice) to: 

Wilmer Cutler Pickering Hale and Dorr LLP 

60 State Street 
 Boston,
Massachusetts 02109 
 Attention: Lia Der Marderosian 

Fax: (617) 526-5000 

Email: Lia.DerMarderosian@wilmerhale.com 

If to the Investors: 
 Only to
the addresses set forth on the signature pages hereto. 
 9.5. Expenses. The parties hereto shall pay their own costs and expenses in
connection herewith regardless of whether the transactions contemplated hereby are consummated; it being understood that each of the Company and each Investor has relied on the advice of its own respective counsel. 

9.6. Amendments and Waivers. Prior to Closing, no amendment or waiver of any provision of this Agreement will be effective with respect
to any party unless made in writing and signed by a duly authorized representative of such party. Following the Closing, any term of this Agreement may be amended and the observance of any term of this Agreement may be waived (either generally or in
a particular instance and either retroactively or prospectively), only with the written consent of the Company and the Required Investors. Notwithstanding the foregoing, this Agreement may not be amended and the observance of any term of this
Agreement may not be waived with respect to any Investor without the written consent of such Investor unless such amendment or waiver applies to all Investors in the same fashion. Any amendment or waiver effected in accordance with this paragraph
shall be binding upon (i) prior to Closing, each Investor that signed such amendment or waiver and (ii) following the Closing, each holder of any Securities purchased under this Agreement at the time outstanding, and in each case, each
future holder of all such Securities and the Company. 
 9.7. Publicity. Except as set forth below, no public release or announcement
concerning the transactions contemplated hereby shall be issued by the Investors without the prior consent of the Company, except as such release or announcement may be required by law or the applicable rules or regulations of any securities
exchange or securities market, in which case the Investors shall allow the Company reasonable time to comment on such release or announcement in advance of such issuance. Notwithstanding the foregoing, each Investor may identify the Company and the
value of such Investor’s security holdings in the Company in accordance with applicable investment reporting and disclosure regulations or internal policies without prior notice to or consent from the Company (including, for the avoidance of
doubt, 

  
 25 

 
filings pursuant to Sections 13 and 16 of the 1934 Act). The Company shall not include the name of any Investor or any Affiliate or investment adviser of such Investor in any press release or
public announcement (which, for the avoidance of doubt, shall not include any SEC Filing to the extent such disclosure is required by SEC rules and regulations) without the prior written consent of such Investor. By 8:30 a.m. (New York City time) on
the Business Day immediately following the date this Agreement is executed, the Company shall issue a press release disclosing all material terms of the transactions contemplated by this Agreement (the “Press Release”). In addition,
the Company will make such other filings and notices in the manner and time required by the SEC or Nasdaq. 
 9.8. Severability. Any
provision of this Agreement that is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof but shall
be interpreted as if it were written so as to be enforceable to the maximum extent permitted by applicable law, and any such prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision in any other
jurisdiction. To the extent permitted by applicable law, the parties hereby waive any provision of law which renders any provision hereof prohibited or unenforceable in any respect. 

9.9. Benefit of Agreement. The Placement Agent is an intended third-party beneficiary of the representations and warranties of the
Company and of each Investor set forth in Section 4 and Section 5, respectively, of this Agreement. 
 9.10. Entire
Agreement. This Agreement, including the signature pages, Exhibits, the other Transaction Documents and the Confidentiality Agreement between the Company and each Investor constitute the entire agreement among the parties hereof with respect to
the subject matter hereof and thereof and supersede all prior agreements and understandings, both oral and written, between the parties with respect to the subject matter hereof and thereof. 

9.11. Further Assurances. The parties shall execute and deliver all such further instruments and documents and take all such other
actions as may reasonably be required to carry out the transactions contemplated hereby and to evidence the fulfillment of the agreements herein contained. 

9.12. Governing Law. This Agreement shall be governed by, and construed in accordance with, the laws of the State of New York. Service
of process in connection with any such suit, action or proceeding may be served on each party hereto anywhere in the world by the same methods as are specified for the giving of notices under this Agreement. 

9.13. Independent Nature of Investors’ Obligations and Rights. The obligations of each Investor under any Transaction Document are
several and not joint with the obligations of any other Investor, and no Investor shall be responsible in any way for the performance of the obligations of any other Investor under any Transaction Document. The decision of each Investor to purchase
Placement Securities pursuant to the Transaction Documents has been made by such Investor independently of any other Investor. Nothing contained herein or in any Transaction Document, and no action taken by any Investor pursuant thereto, shall be
deemed to 

  
 26 

 
constitute the Investors as a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Investors are in any way acting in concert or as a group
with respect to such obligations or the transactions contemplated by the Transaction Documents. Each Investor acknowledges that no other Investor has acted as agent for such Investor in connection with making its investment hereunder and that no
Investor will be acting as agent of such Investor in connection with monitoring its investment in the Securities or enforcing its rights under the Transaction Documents. Each Investor shall be entitled to independently protect and enforce its
rights, including, without limitation, the rights arising out of this Agreement or out of the other Transaction Documents, and it shall not be necessary for any other Investor to be joined as an additional party in any proceeding for such purpose.
The Company acknowledges that each of the Investors has been provided with the same Transaction Documents for the purpose of closing a transaction with multiple Investors and not because it was required or requested to do so by any Investor. It is
expressly understood and agreed that each provision contained in this Agreement is between the Company and an Investor, solely, and not between the Company and the Investors collectively and not between and among the Investors. 

9.14. Exculpation of the Placement Agent. Each party hereto agrees for the express benefit of the Placements Agent and its affiliates
and representatives that: 
 (i) none of the Placement Agent, its affiliates or any of its representatives (1) has any duties or
obligations other than those specifically set forth herein or in the engagement letter, dated as July 17, 2019 (the “Engagement Letter”), between the Company and the Placement Agent; (2) shall be liable for any improper
payment made in accordance with the information provided by the Company; (3) makes any representation or warranty, or has any responsibilities as to the validity, accuracy, value or genuineness of any information, certificates or documentation
delivered by or on behalf of the Company pursuant to this Agreement or the Transaction Documents or in connection with any of the transactions contemplated hereby and thereby; or (4) shall be liable (x) for any action taken, suffered or
omitted by any of them in good faith and reasonably believed to be authorized or within the discretion or rights or powers conferred upon it by this Agreement or any Transaction Document or (y) for anything which any of them may do or refrain
from doing in connection with this Agreement or any Transaction Document, except in each case for such party’s own gross negligence, willful misconduct or bad faith. 

(ii) The Placement Agent, its affiliates and its representatives shall be entitled to (1) rely on, and shall be protected in acting upon,
any certificate, instrument, notice, letter or any other document or security delivered to any of them by or on behalf of the Company, and (2) be indemnified by the Company for acting as the Placement Agent hereunder pursuant to the
indemnification provisions set forth in the Engagement Letter. 
 [remainder of page intentionally left blank] 

  
 27 

 IN WITNESS WHEREOF, the parties have executed this Agreement or caused their duly authorized
officers to execute this Agreement as of the date first above written. 
  

									
	COMPANY:	 		 	SOLID BIOSCIENCES INC.
					
		 		 		 	By:	 	/s/ Ilan Ganot
		 		 		 		 	Name: Ilan Ganot
		 		 		 		 	Title: Chief Executive Officer

  

									
	INVESTOR:	 		 	DTMG Bermuda Limited
					
		 		 		 	By:	 	/s/ Gilad Hayeem
		 		 		 		 	Name: Gilad Hayeem
		 		 		 		 	Title: Director

  

									
	 INVESTOR:
	 		 	
					
		 		 		 	By:	 	/s/ Martin Freed
		 		 		 		 	 Name: Martin Freed

  

									
	 INVESTOR:
	 		 	
					
		 		 		 	By:	 	/s/ Matthew B. Arnold
		 		 		 		 	 Name: Matthew B. Arnold

  

									
	 INVESTOR:
	 		 	
					
		 		 		 	By:	 	/s/ Sukumar Nagendran
		 		 		 		 	 Name: Sukumar Nagendran

  

									
	INVESTOR:	 		 	Blackwell Partners LLC – Series A
					
		 		 		 	By:	 	/s/ Abayomi A. Adigun
		 		 		 		 	 Name: Abayomi A. Adigun

		 		 		 		 	 Title: Authorized Agent

					
		 		 		 	By:	 	/s/ Jannine M. Lall
		 		 		 		 	 Name: Jannine M. Lall

		 		 		 		 	 Title: Authorized Agent

									
	INVESTOR:	 		 	RA Capital Healthcare Fund, L.P.
					
		 		 		 	By:	 	RA Capital Management, LLC
		 		 		 	Its:	 	General Partner
					
		 		 		 	By:	 	/s/ Rajeev Shah
		 		 		 		 	Name: Rajeev Shah
		 		 		 		 	Title: Authorized Signatory

  

									
	INVESTOR:	 		 	MVA Investors, LLC
					
		 		 		 	By:	 	/s/ Aaron Davis
		 		 		 		 	 Name: Aaron Davis

		 		 		 		 	 Title: Chief Executive Officer

 

									
	INVESTOR:	 		 	Boxer Capital, LLC
					
		 		 		 	By:	 	/s/ Aaron Davis
		 		 		 		 	 Name: Aaron Davis

		 		 		 		 	 Title: Chief Executive Officer

 

									
	INVESTOR:	 		 	Invus Public Equities, L.P.
					
		 		 		 	By:	 	 /s/ Philip Bafundo

		 		 		 		 	 Name: Philip Bafundo

		 		 		 		 	 Title: CFO of the General
Partner

  

									
	INVESTOR:	 		 	
					
		 		 		 	By:	 	 /s/ Carl Morris

		 		 		 		 	 Name: Carl Morris

 

									
	INVESTOR:	 		 	
					
		 		 		 	By:	 	 /s/ Ilan Ganot

		 		 		 		 	 Name: Ilan Ganot

  
 29 

							
	 INVESTOR:
	 		 	EcoR1 Capital Fund, LP
				
		 		 	By:	 	 /s/ Oleg Nodelman

		 		 		 	Name: Oleg Nodelman
		 		 		 	Title: Manager, EcoR1 Capital LLC, as GP
			
	 INVESTOR:
	 		 	EcoR1 Capital Fund Qualified, LP
				
		 		 	By:	 	 /s/ Oleg Nodelman

		 		 		 	Name: Oleg Nodelman
		 		 		 	Title: Manager, EcoR1 Capital LLC, as GP
			
	 INVESTOR:
	 		 	BCLS SB Investco, LP
				
		 		 	By:	 	 /s/ Jeffrey Schwartz

		 		 		 	Name: Jeffrey Schwartz
		 		 		 	Title: Managing Director
			
	 INVESTOR:
	 		 	Perceptive Life Sciences Master Fund, Ltd.
				
		 		 	By:	 	 /s/ Alexander Rakitin

		 		 		 	Name: Alexander Rakitin
		 		 		 	Title: Chief Compliance Officer

  
 30 

 EXHIBIT A 

Schedule of Investors 
  

													
	 Investor Name
	  	Number of
Shares to be
Purchased	 	  	Number of Warrant
Shares Underlying
Pre-Funded
Warrant Purchased	 	  	Aggregate Purchase Price
of Placement Securities	 
	 EcoR1 Capital Fund Qualified, LP
	  	 	1,567,604	 	  	 	—  	 	  	$	7,289,358.60	 
	 EcoR1 Capital Fund, LP
	  	 	314,116	 	  	 	—  	 	  	$	1,460,639.40	 
	 DTMG Bermuda Limited
	  	 	903,226	 	  	 	—  	 	  	$	4,200,000.90	 
	 Invus Public Equities, L.P.
	  	 	430,108	 	  	 	—  	 	  	$	2,000,002.20	 
	 Perceptive Life Sciences Master Fund, Ltd.
	  	 	2,822,581	 	  	 	—  	 	  	$	13,125,001.65	 
	 BCLS SB Investco, LP
	  	 	1,881,720	 	  	 	—  	 	  	$	8,749,998.00	 
	 RA Capital Healthcare Fund, L.P.
	  	 	1,593,629	 	  	 	—  	 	  	$	7,410,374.85	 
	 Blackwell Partners LLC
	  	 	288,091	 	  	 	—  	 	  	$	1,339,623.15	 
	 Matthew B. Arnold
	  	 	677,419	 	  	 	—  	 	  	$	3,149,998.35	 
	 Martin I. Freed
	  	 	53,763	 	  	 	—  	 	  	$	249,997.95	 
	 Sukumar Nagendran
	  	 	32,258	 	  	 	—  	 	  	$	149,999.70	 
	 Ilan Ganot
	  	 	21,505	 	  	 	—  	 	  	$	99,998.25	 
	 Carl Morris
	  	 	21,505	 	  	 	—  	 	  	$	99,998.25	 
	 MVA Investors, LLC
	  	 	—  	 	  	 	137,370	 	  	$	637,396.80	 
	 Boxer Capital, LLC
	  	 	—  	 	  	 	2,158,329	 	  	$	10,014,646.56	 
		  	  
	  
	 	  	  
	  
	 	  	  
	  
	 
	 TOTAL
	  	 	10,607,525	 	  	 	2,295,699	 	  	$	59,977,034.61

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00298-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00298-of-00352.parquet"}]]